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2. ABSTRACT
Adeno-associated virus type 2 (AAV-2) is a nonpathogenic, replication 
defective parvovirus containing a single-stranded DNA genome of 4.7 kb. 
Despite the increasing utilization of recombinant vectors derived from this virus 
(rAAV) in gene transfer applications, several aspects of the biology of both the 
wild type virus and of its vectors remain poorly understood. Here we developed a 
technique to visualize the conversion of rAAV vector genomes from single­
stranded (ss) to double-stranded (ds) DNA in real time. We report that rAAV 
DNA accumulates into discrete foci inside the nucleus. These rAAV foci are 
defined in number, increase in size over time after transduction, and their 
presence correlates with the efficiency of cell transduction. These structures 
overlap with, or lie in close proximity to, the foci in which proteins of the MRN 
(Mrell-Rad50-Nbsl) complex and Mdcl accumulate after DNA damage. 
Silencing of Nbsl or Mdcl by RNA interference markedly increases the 
formation of rAAV foci, the extent of rAAV transduction, and AAV Rep 
dependent site-specific integration at chromosome 19q.l3.3-qter, so called 
AAVS1 locus. The adenovirus E4orf6 and ElB55k proteins-mediated 
degradation of the MRN complex also correlated with high levels of rAAV 
transduction and foci formation. Taken together, these observations indicate that 
the MRN complex plays an inhibitory role at the level of rAAV ss to double­
stranded DNA (dsDNA) genome conversion, vector transduction, and site- 
specific integration. On the other hand, similar experiments using siRNAs against 
histone H2AX, Rad52, and DNA-PKcs indicated that these factors are required 
for effective rAAV transduction and site-specific integration.
83. INTRODUCTION
3.1. The Adeno-Associated Virus Type 2 (AAV-2).
Adeno-Associated Virus type 2 (AAV-2) was first discovered as a 
contaminant of Adenovirus stocks produced in African green monkey kidney cells 
(Hoggan et al., 1966). In fact, AAV-2 is unique among human viruses because its 
productive replication in cell culture is strictly dependent on the concomitant 
superinfection of the host cells by another non-related helper virus (Adenovirus or 
Herpes Simplex Virus) (Buller et al., 1981; Hoggan et al., 1966). The helper 
functions can also be provided by a wide variety of genotoxic agents, in which 
case AAV can replicate at low levels (Yakobson et al., 1987). In the absence of 
helper functions, AAV establishes a latent infection in the host cell by integrating 
site specifically on the long arm of human chromosome 19 (19ql3.3-qter) (Kotin 
et al., 1992; Kotin et al., 1991; Kotin et al., 1990; Samulski et al., 1991). Once 
integrated, the provirus is passively replicated along with cellular DNA, until a 
new helper stimulus is provided (Cheung et al., 1980; Hoggan et al., 1966). In 
this case, the integrated provirus can be rescued from its chromosomal state and 
start replicating again (Cheung et ah, 1980) (see Figure 3.1).
Given the need for viral helper functions for its fully replication activity, 
and since it is one of the smallest DNA viruses known so far, AAV was originally 
classified as a member of the Parvoviridae family, genus Dependovirus (Siegl et 
al., 1985). Furthermore, more recently it was possible to isolate different AAVs 
based on their serological properties (from AAV-1 to AAV-9, for a review see 
(Gao et al., 2005; Wu et al., 2006)). Nonetheless, AAV-2 is the one that has been 
studied more extensively, thus we will focus our attention on this serotype, except 
where explicitly mentioned. Another very peculiar feature of this virus is that, 
despite several attempts to demonstrate a possible pathogenic role for AAV, it has
been impossible to correlate infection with any known disease, despite 90% of the 
adult population known to have antibodies against this virus and thus been in 
contact with it (Blacklow et al., 1971). More than ten years ago, a couple of 
reports showed the presence of AAV DNA in 40% of the samples obtained from 
spontaneous abortions. No follow up has been provided for this indication, and no 
conclusion from these data can therefore be drawn (Botquin et al., 1994; Tobiasch 
et al., 1994).
In summary, AAV-2 cannot be considered pathogenic in humans and it 
can site specifically integrate at high frequency in a specific locus of the human 
genome.
For these reasons, and for its ability to transduce post-mitotic tissues like 
skeletal muscle and nervous cells, AAV-2 has emerged as one of the most 
promising viral vectors for gene therapy. In addition, AAV-2 is considerably less 
immunogenic than other viruses, such as Adenovirus, which are used in gene 
therapy. Thus, in recent years much of the interest in the AAV field has been 
devoted to the development and production of safer and more efficient rAAV 
vectors for the treatment of a wide array of diseases (for a recent review see 
(Flotte, 2004)). On the other hand, these practical applications in the Molecular 
Medicine field have also fuelled researchers’ interest in studying AAV-2 
molecular biology to get new insight into the basic mechanisms that govern its 
infection of the host cell.
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Figure 3.1. The Adeno-associated virus life cycle.
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3.1.1. The Adeno-associated virus genome.
The AAV genome is a single stranded DNA molecule of 4,679 nucleotides 
(Srivastava et al., 1983), and contains three main genetic elements: two 145 base- 
pair (bp) inverted terminal repeats (ITR) that are present at each end of the 
genome and two open reading frames, called Rep and Cap (Lusby et al., 1980) 
(see Figure 3.2).
The ITRs are formed by a palindromic sequence of 125 nucleotides (A) 
(nucleotides 1-41 and 85 to 125) interrupted by two shorter palindromes (B and 
C) (nucleotides 42 to 84) (see Figure 3.3). To maximize base pairing and 
thermodynamic stability, each ITR can fold on itself forming a T shaped closed 
hairpin. Furthermore, one of the ITR in its closed, base paired conformation 
provides a free 3’ OH for the start of DNA replication. In addition, the ITR 
contains three DNA sequences that are important for binding of the large Rep 
proteins: the Rep binding site (RBS), which is a tetrad-repeat of the GAGC 
sequence (Chiorini et al., 1994a; Chiorini et al., 1994b; Owens et al., 1993); the 
RBS’, in one of the two bulges of the T hairpin (Brister and Muzyczka, 2000), 
and the terminal resolution site (trs) between nucleotides 124 and 125, which is 
site and strand specifically nicked by Rep during the process of AAV replication 
(Im and Muzyczka, 1990). All these features make the ITR the only in cis signal 
necessary for AAV replication, transcription, site-specific integration and rescue 
of the provirus from the dsDNA integrated state.
The AAV genome is transcribed from three promoters, p5, p i9 and p40 
that produce several polyadenylated mRNAs (Green and Roeder, 1980; Laughlin 
et al., 1979) (See Figure 3.2). Rep 78 and Rep68 are produced by alternative 
splicing of a single immature mRNA that is transcribed from the p5 promoter 
(Green and Roeder, 1980). The same gene is transcribed from a downstream
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promoter, p i9, and an alternative start site is used to produce Rep52 and Rep40 
by alternative splicing. It is worth mentioning that all these four proteins are 
colinear and thus the two shorter isoforms represent the C-terminus of the larger 
ones.
The Cap ORF is transcribed from the p40 promoter and produces two 
alternatively spliced mRNAs, from which the three capsid proteins (VP1, VP2 
and VP3) are generated, due to the presence of a non canonical ATG start site for 
translation in one of them (Becerra et al., 1988).
Originally, the left ORF was named Rep because several mutations in this 
region led to the generation of a replication incompetent AAV (Hermonat et al., 
1984). Later on, these initial results could be rationalized by considering that 
these mutations affected the two larger Rep proteins (Rep78 and Rep68). On the 
contrary, viruses in which the AUG start site of the shorter Rep proteins (Rep52 
and Rep40) was mutated to GGG were still proficient in replication but did not 
form infectious particles (Chejanovsky and Carter, 1989). This phenotype was 
similar to the one observed in some cap mutants, which in fact were still able to 
replicate but failed to accumulate ssDNA viral genomes, a process associated with 
packaging (Hermonat et al., 1984).
Recombinant AAV (rAAV) vectors can be easily produced by replacing 
all the coding regions with an expression cassette for the gene of interest flanked 
by the ITRs of the wild type virus (Hermonat and Muzyczka, 1984; Tratschin et 
al., 1984). Their natural replication incompetence, the lack of identified 
pathogenicity, the simplicity of their genetical manipulation, as well as the 
possibility to produce viral vectors that do not contain any gene from the wild- 
type virus, make the rAAV vectors one of the most attractive viral vectors in the 
gene therapy arena.
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3.1.2. AAV-2 Rep proteins and their biochemical activities.
Rep78, Rep68, Rep52 and Rep40 were named according to their apparent 
molecular weight on SDS-PAGE gels. Various biochemical activities have been 
ascribed to the Rep proteins and now a great deal of information has been 
gathered on their function (Figure 3.4).
Rep68 and Rep78, which are 536 and 621 amino-acids (aa) long, are 
endowed with specific dsDNA binding activity toward the ITR (Ashktorab and 
Srivastava, 1989; Im and Muzyczka, 1989; Im and Muzyczka, 1990; Owens et al., 
1993; Snyder et al., 1993), while Rep52 and Rep40 are not (Im and Muzyczka, 
1992). Several residues have been shown to be fundamental for the DNA binding 
activity of Rep. These include Arg 107 and Arg 138, which make contacts with 
DNA bases, and Lys 136, which forms a salt bridge with the phosphate backbone 
of DNA (Hickman et al., 2004). The RBS is the minimal requirement for Rep 
binding to the ITR, however, in the presence of the hairpin that contains the RBS 
sequence, the efficiency of nicking increases up to 100 fold, (Brister and 
Muzyczka, 2000; Chiorini et al., 1994b; Ryan et al., 1996). Rep78 and 68 also 
possess site- and strand-specific nicking activity toward the trs sequence (Im and 
Muzyczka, 1990). This activity can be mapped to the first 208 aa of Rep78, 
which are sufficient when the trs sequence is in single-stranded conformation 
(Yoon-Robarts and Linden, 2003). In particular, Tyrl56 of Rep is actively 
involved in the catalysis through a trans-esterification reaction. As a result of the 
DNA cleavage, this residue remains covalently linked to the 5’ end of the cut 
DNA (Smith and Kotin, 2000; Snyder et al., 1990). The cutting of the trs is also 
dependent on metal binding, probably through two histidines (His90 and His92), 
Glu83 and Asp412 (Gavin et al., 1999; Hickman et al., 2002; Urabe et al., 1999; 
Yoon-Robarts and Linden, 2003). More recently, structural studies on the
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crystallized first 197 aa of AAV-5 Rep (alone or in the presence of RBS and RBS’ 
oligonucleotides) have provided new insight into these two biochemical activities 
(Hickman et al., 2002; Hickman et al., 2004). These studies have determined that 
the N-terminus of Rep proteins belongs to the RCR (Rolling Circle Replication) 
family, which includes several viral replication proteins that use a catalytic 
tyrosine, such as SV40 T antigen and BPV El (Hickman et al., 2002). These and 
other studies also confirmed what had been observed in the past: Rep proteins 
bind RBS DNA as an hexamer (Hickman et al., 2002), and the oligomerization is 
stimulated by ATP and DNA (Li et al., 2003; Smith et al., 1997). The region 
important for oligomerization can be mapped to aa 164-484, and in these 321 aa 
two regions are important: a putative alpha-helix bearing a 3,4-hydrophobic 
heptad repeat reminiscent of those found in coiled-coil domains, and the 
previously recognized nucleoside triphosphate-binding motif (aa 334-349) (Smith 
et al., 1997).
The domain comprised between aa 224-526 (the residues shared by all the 
four isoforms) is endowed with ATP-dependent helicase activity (Im and 
Muzyczka, 1990; Im and Muzyczka, 1992). Mutation K340H, which disrupts 
ATP binding, completely inhibits helicase activity and acts as dominant negative 
in AAV replication when inserted in the context of Rep78 (Chejanovsky and 
Carter, 1990). In contrast, the same mutation in Rep52 does indeed disrupt the 
ATPase activity of the protein but does not inhibit replication, probably reflecting 
differences in the capability of forming holocomplexes between the long and the 
short isoforms of Rep (Smith and Kotin, 1998). Rep K340H is also unable to 
inhibit transcriptional activation from the AAV p5 promoter (Kyostio et al., 
1995). ATP-dependent helicase activity is also important for Rep nicking of the 
trs, when the latter is in a double-stranded conformation (Brister and Muzyczka,
17
1999; Im and Muzyczka, 1990). This last observation suggests that Rep is 
capable of cutting only a single stranded trs substrate, which is probably formed 
by DNA melting achieved through the action of the helicase domain. The two 
short isoforms (Rep40 and Rep52) retain ATPase and 3’-5’ helicase activity 
(Smith and Kotin, 1998), and through these two activities they are able to 
encapsidate replicated AAV genomes into preformed capsids by forming a 
complex with the two largest Rep proteins (King et al., 2001).
The C-terminal region of Rep78 and Rep52 consists of a Zinc-Finger 
domain that is not present in Rep68 and Rep40. This domain is not essential for 
any of the Rep activities (Im and Muzyczka, 1990; Ni et al., 1994). Nevertheless, 
this domain is involved in the G2 /M cell cycle arrest and hyper-phosphorylation of 
Rb caused by the expression of Rep78 (Saudan et al., 2000). The Zinc Finger 
domain is also required for the interaction between Rep78 and the 
Serine/threonine-protein kinase X-linked (PRKX) and the inhibition of CREB- 
dependent transcription (Di Pasquale and Stacey, 1998).
3.1.3. Adeno-associated virus 2 transcription.
Regulation of AAV transcription has been widely studied and it appears 
that many layers of regulation are involved, depending on the cellular context in 
which AAV is present. Briefly, when the helper functions are not provided, p5, 
p i9 and p40 are silenced. The inhibition of p5 depends on several in cis 
sequences that have been mapped; including an RBS upstream of the start site, a 
TATA box and a binding site for the cellular factor YY1 (McCarty et al., 1994). 
In the latent state, Rep78, which is produced in small amounts, actively represses 
p5 in an ATP-dependent manner (Kyostio et al., 1995). At the same time Rep78 
can also inhibit transcriptional activity from the p i 9 promoter, even if there is no
18
strong consensus RBS sequence in this region. Thus it appears that Rep 
repression of promoters depends in part on its binding to the RBS, but also on its 
interaction with cellular transcription factors.
When Adenovirus infects the cell, the transcriptional regulation of AAV 
promoters is profoundly modified. By interfering with YY1 (Shi et al., 1991), 
Adenovirus El A protein contributes to activate p5, which in turn produces 
transcripts that encode for Rep78 and Rep68 (Chang et al., 1989). In the presence 
of co-infecting Adenovirus and a functional p5, RBS can activate the p i9 and p40 
promoters, thus producing Rep52, Rep40 and the capsid proteins (Pereira et al.,
1997). Rep78 and Rep68 are necessary for the Adenovirus-dependent activation 
of the p i9 promoter, since through protein-protein interactions they promote the 
formation of a DNA loop that brings transcriptional activators present on p5 into 
the proximity of p l9  (Lackner and Muzyczka, 2002); this event requires an intact 
p5 RBS and an intact Spl site upstream of p i9. In the same conditions, Rep78 
and Rep68 continue to repress the p5 promoter, in a sort of feedback loop (Pereira 
et al., 1997). The role of HSV-1 genes in the reactivation of AAV transcription 
has been studied less. More recent experimental evidence highlights a role for 
HSV-1 ICPO in the activation of Rep transcription from a chromatin embedded p5 
promoter (Geoffroy et al., 2004). Interestingly, this activity is dependent on an 
intact RING domain present in ICPO (that possesses E3 ubiquitin ligase activity) 
and on the proteasome pathway.
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3.1.4. Adeno-associated virus 2 replication.
AAV replicates through a strand displacement mechanism that was first 
proposed by Tattersall and Ward (Tattersall and Ward, 1976). The AAV genome 
enters into the infected cell as hairpinned ssDNA. The 3’ OH of one of the ITRs 
provides a free end for the initiation of replication of the second strand by cellular 
replication enzymes. The linear dsDNA molecule generated in this way is closed 
at one end and it must be opened to replicate all the AAV genome (Figure 3.5). 
This operation is carried out by Rep78 or Rep68 that bind the ITR and cut the trs 
at position 124 only on the original strand, thus generating a free 3’ OH on the 
same strand and transferring the “old” hairpin onto the newly formed DNA 
filament. The resulting gap in the complementary strand is filled by cellular 
polymerases and a complete blunt ended double stranded AAV molecule is 
formed. At this point the newly generated ITR at the end of the original strand is 
displaced by the helicase activity of Rep and can fold on itself again, thus giving 
rise to another origin of replication. A closed dsDNA molecule is produced, 
resembling the intermediate generated at the first step, thus providing a substrate 
for subsequent rounds of replication. At the same time, a single stranded AAV 
genome is formed, ready to be packed into newly formed virions. Larger double 
stranded AAV replication intermediates corresponding to the size of dimers, 
trimers and tetramers are observed both in vivo and in vitro (Ni et al., 1998; Ni et 
al., 1994; Straus et al., 1976; Ward et al., 1998). They are the product of missing 
terminal resolution nicking by Rep when a new double-stranded AAV template is 
produced.
Several factors affect AAV replication. Either Rep78 or Rep68 must be 
present (Ni et al., 1994), whereas isolated Rep52 is not functional. This 
demonstrates that both DNA binding and trs endonuclease activities are requires.
Furthermore, a cell extract of uninfected HeLa cells is not capable of supporting 
replication, demonstrating the need of helper functions provided by Adenovirus 
(Ni et al., 1994; Ward et al., 1994). In particular, it seems that these functions are 
not involved in increasing the efficiency of initiation of replication, but they rather 
augment the processivity of the reaction (Ni et al., 1994; Ward et al., 1994). 
Interestingly, extracts from HeLa cells that are grown at high density support 
replication as much as the ones obtained from Adenovirus infected cells (Ni et al.,
1998). Replication is also dependent on the presence of ATP and Mg’*-1- (Ni et al.,
1994), a fact that mirrors the need of these factors for Rep helicase and 
endonuclease activity (Im and Muzyczka, 1990). The fact that cells under stress 
are permissive for replication strongly indicates that, beside Rep, all the factors 
involved in AAV replication are of cellular origin (Ni et al., 1998). The same set 
of studies, however, failed to reconstitute AAV replication in vitro entirely with 
purified cellular proteins. Nevertheless, it was possible to establish, by 
immunodepeletion of nuclear extracts, that the ssDNA binding protein 
Replication Protein A (RPA), Proliferating nuclear antigen (PCNA), the 
Replication Factor C (RFC) are necessary for AAV replication (Ni et al., 1998; 
Ward et al., 1998). In fact, RPA binds Rep78 and Rep68 and enhance their DNA 
binding and endonuclease activities (Stracker et al., 2004).
So far, the only experimental approach that supported AAV in vitro 
replication only using recombinant proteins is the one described by Ward et al., 
who used recombinant Rep and a subset of purified HSV-1 proteins (UL5, UL8, 
UL29, UL30, UL42, and UL52) (Ward et al., 2001).
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3.1.5. Adeno-associated virus 2 integration.
AAV replicates and undergoes lytic infection only in the presence of a 
helper stimulus. Site-specific integration, on the other hand, is the mechanism 
that AAV employs to establish latent infection of the host cell when such helper 
functions are absent (Hoggan et al., 1966).
AAV is unique among human viruses because it can integrate in a specific 
region of the genome on chromosome 19ql3.3-qter (Samulski et al., 1991). This 
process is strictly dependent on the presence and the activity of Rep proteins, 
since rAAV vectors that are devoid of viral genes integrate at random and at a 
lower efficiency compared to wt AAV. The region of site-specific integration in 
chromosome 19 was sequenced and named AAVS1 (Kotin et al., 1992). 
Furthermore, Dutheil et al. have shown that AAVS1 is in the same locus as a 
muscle specific gene coding for slow skeletal Troponin (TNNT1), which maps to 
chromosome 19.ql3.4 in humans (Dutheil et al., 2000). The mouse ortholog of 
AAVS1 has also been identified in the mouse genome but there is still no 
evidence that AAV integration can occur site-specifically at this region (Dutheil et 
al., 2004). Sequencing of the junctions between cellular and viral DNA also 
showed that the integration process causes deletion, amplifications and 
rearrangements of viral and cellular sequences. The presence of an RBS in 
AAVS1 and the fact that Rep can bind both this sequence and the RBS present in 
the virus ITR suggests that Rep complexes might bridge together cellular and 
AAV sequences in the process of integration (Weitzman et al., 1994). In the same 
region a trs sequence is also present, and in fact Rep can nick DNA at this 
chromosomal site and asymmetrically replicate only one of the two strands, thus 
explaining the existence of extensive sequence rearrangements following AAV 
integration into AAVS1 (Linden et al., 1996b). Integration probably involves
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some degree of replication of the chromosomal DNA, as shown by the presence 
of head to tail concatamers, but, surprisingly, the RBS present in the ITR of the 
viral genome is not necessary for this process (Young and Samulski, 2001).
The mechanisms influencing AAV site-specific integration are poorly 
understood. Approximately 2x105 RBS are present throughout the genome 
(Young et al., 2000). Given that Rep binds all these sites with the same affinity, 
the presence of RBS and trs sequences in the proper orientation and at the proper 
distance only in AAVS1 (and not in other regions of the human genome) might 
explain the target region selectivity (Young et al., 2000). Moreover, the AAVS1 
region seems to be embedded in a transcriptional competent region (possibly 
determined by the presence of an enhancer element) and in an open chromatin 
conformation, thus providing accessibility to the action of Rep proteins in 
integration (Lamartina et al., 2000).
It is worth noting that the vast majority of rA W  vectors used in gene 
therapy applications do not contain the Rep ORF and thus do not integrate site- 
specifically
There is a growing concern that the use of viral vector in gene therapy 
may generate, as previously observed in clinical cases (Dave et al., 2004; Hacein- 
Bey-Abina et al., 2003), insertional mutagenesis in the treated patient leading to 
eventual cell transformation and carcinogenesis (Baum et al., 2004; Nakai et al., 
2003). For this reason, understanding the mechanism of AAV Rep site-specific 
integration will be invaluably useful for the future development of new 
generations of viral and non-viral vectors that could target specifically their site of 
integration into the host genome.
3.1.6. Viral helper functions.
As mentioned earlier, AAV gene expression and productive replication are 
strictly dependent on helper functions provided either by other co-infecting 
viruses or various insults to the host cell. As far as Adenovirus is concerned, four 
of its proteins have been shown to provide helper functions to AAV. The product 
of the Adenovirus El A gene is required for relieving Rep inhibition of the p5 and 
p l9  promoters (Chang et al., 1989). Adenovirus VA1 RNA, instead, is probably 
involved in facilitating the initiation of protein translation. An Adenovirus 
deleted in the E2A gene (coding for the Adenovirus ssDNA binding protein) is 
still able to provide helper functions to AAV replication (Carter et al., 1992). 
Nevertheless, Adenovirus E2A seems to help AAV replication by increasing the 
processivity of DNA replication, by directly increasing Rep78 and Rep68 DNA 
binding and endonuclease activities (Stracker et al., 2004), thus possibly 
substituting for cellular RPA (Ward et al., 1998).
The most compelling evidences for an Adenovirus helper function have 
pointed toward the complex ElB55kD/E4orf6. In fact, this complex might 
influence the AAV replication cycle at many steps, for example by enhancing 
transport of mature AAV from the nucleus to the cytoplasm (Samulski and Shenk, 
1988). It has been also reported that ElB55k and E4orf6 form a complex that 
degrades the MRN complex components and p53 protein (Stracker et al., 2002). 
The degradation of the MRN complex severely impairs the capacity of the cell to 
elicit a DNA damage response that would otherwise limit adenovirus replication 
(Carson et al., 2003). Furthermore, E4orf6 and ElB55k increase the transduction 
levels of a rAAV vector, probably by enhancing the efficiency of the second 
strand synthesis (Ferrari et al., 1996). Also, Weitzman and collaborators showed 
that Cyclin A is degraded upon E4orf6 expression, and that this correlates with an
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intra S-phase arrest. This observation was correlated to rAAV transduction by 
demonstrating that over-expression of Cyclin A inhibited E4orf6 helper activity 
(Grifman et al., 1999).
As for HSV, four genes provide helper functions to AAV: the UL5/8/52 
(helicase primase complex) and UL29 (ssDNA binding protein, also known as 
ICP8) are able to support AAV replication in vivo (Stracker et al., 2004; Weindler 
and Heilbronn, 1991) and in vitro (Plus UL30, the HSV polymerase) in the 
presence of recombinant Rep68 (Ward et al., 2001).
3.1.7. Effects of Rep proteins on transcription, cell cycle and cell 
transformation.
Besides playing a direct role in AAV biology, the Rep proteins are also 
capable of influencing the state of the host cell and to inhibit the replication of 
helper viruses.
First, Rep proteins induce arrest of cell proliferation that can be reversed 
by eliminating their expression (Yang et al., 1994). Second, it has been proven 
that Rep can interfere with the DNA replication of SV40 (Becerra et al., 1988), 
HPV16 (Marcello et al., 2000) and HSV-1 (Kleinschmidt et al., 1995). Third, 
Rep are able to suppress cellular transformation caused by oncogenes like c-H-ras 
(Batchu et al., 1994) and by oncoviruses like Adenovirus (de la Maza and Carter, 
1981) and HPV16 (Human Papillomavirus 16) (Walz et al., 1997). Two possible, 
not mutually exclusive, explanations can be invoked for these observations.
First, Rep cytostatic activity can be correlated with the ability of inducing 
either a S-phase (Rep78) or a G2 /M (Rep68) cell cycle arrest by increasing the 
levels of phosphoryated pRb and p21 (Hermanns et al., 1997; Saudan et al.,
2000). Second, it is likely that Rep anti-oncogenic and anti-proliferative
properties on such different biological systems are due to the inhibitory activity of 
Rep on transcription. In fact, Rep does not only regulate transcription from its 
own promoters but it also inhibits transcriptional activity from several 
heterologous cellular and viral promoters such as c-fos, c-myc (Hermonat, 1994), 
c-H-ras (Batchu et al., 1994), HIV-1 LTR (Horer et al., 1995) and HPV URR 
(Horer et al., 1995; Marcello et al., 2000). Rep transcriptional regulation is likely 
achieved by different mechanisms. Promoters containing strong RBS, like AAV 
p5 (McCarty et al., 1994) and c-H-ras (Batchu et al., 1994), are directly bound by 
Rep and then actively inhibited by it. Nonetheless, Rep binding to DNA elements 
in the regulatory regions of these genes cannot be invoked as the sole mechanism 
to explain transcriptional inhibition. In fact some of these genes, like the HPV 18 
URR and the HIV-1 LTR, do not contain an RBE in their promoter (Horer et al.,
1995). In these cases it is conceivable that Rep regulates transcription through 
protein-protein interactions either with basal components of the transcriptional 
apparatus like TBP (Hermonat et al., 1998) and Spl (Hermonat et al., 1996), or 
with transcriptional co-activators like PC4 (Weger et al., 1999) and HPV16 E2 
(Marcello et al., 2000).
It has been also recently reported that Rep78 inhibits Cdc25 A activity by a 
novel mechanism, in which binding between the two proteins stabilizes Cdc25A, 
thus increasing its abundance, while at the same time preventing access to its 
substrates cyclin-dependent kinase (Cdk) 2 and Cdkl. This effect alone does not 
induce a complete S phase block. In addition, Rep78, as well as Rep68, produces 
nicks in the cellular chromatin, inducing a DNA damage response mediated by 
ataxia telangiectasia mutated (ATM) leading to G1 and G2 cell cycle arrest 
(Berthet et al., 2005).
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3.2. Genome stability -  Recognition and repair of DNA Double strand 
breaks
In eukaryotic cells, efficient surveillance mechanisms have evolved to 
rapidly recognize DNA damage and to signal its presence. DNA damage can 
dramatically impair cell function, leading to cellular transformation and 
carcinogenesis, or inducing cycle arrest and eventually cell death (van Gent et al., 
2001). Of the various forms of damage that can be inflicted, probably the most 
dangerous is represented by DNA double-strand breaks (DSBs). These are created 
when a DNA lesion is composed of two or more strand breaks at approximately 
the same nucleotide pair simultaneously cuts a DNA molecule into smaller 
fragments. (Jackson, 2002; Khanna and Jackson, 2001; Rich et al., 2000). DSBs 
can be generated after cell exposure to endogenous or exogenous agents. Some of 
the exogenous agents that can produce DSBs are: ionizing radiation (IR), 
genotoxic, and radiomimetic or chemotherapeutics drugs like hydroxyurea, 
camptothecin, etoposide, and bleomycin, (Povirk, 1996). Among the principal 
endogenous agents that can lead to the formation of DSBs are the Reactive 
Oxygen Species (ROS), typically produced during normal metabolic reactions 
(Barzilai and Yamamoto, 2004; Storz, 2005). Double strand breaks can also be 
produced during recombination processes like meiotic recombination and, V(D)J 
and immunoglobulin isotype class switch recombination (Khanna and Jackson,
2001), as well as during cellular DNA replication through damaged or nicked 
DNA (Robison et al., 2004) or during aberrant processing of telomeres (Reaper et 
al., 2004)
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3.2.1. Early events after DNA DSB breaks and sensing.
Detection of DNA double-strand breaks involves sensor proteins that 
become activated and trigger several signaling cascades. This signaling leads to 
the recruitment of specialized proteins to the site of damage that contribute to the 
subsequent repair of the damaged DNA. One of the first described events after 
DNA DSBs is the phosphorylation of the histone H2AX (y-H2AX). The 
phosphorylation of H2AX on serine 139 occurs very rapidly and depends on 
ATM, ATR and DNA-dependent protein kinase (DNA-PK) (Burma et al., 2001; 
Mukherjee et al., 2006). y-H2AX foci are typically visible by 
immunofluorescence few minutes after induction of DSBs upon treatment of cells 
with ionizing radiation, but they are also formed at sites of stalled replication 
forks (Furuta et al., 2003; Rogakou et al., 1998).
In particular, DNA double-strand breaks in chromosomal DNA elicit a 
signaling response through the ataxia-telangiectasia mutated (ATM) protein 
kinase, which coordinates cell-cycle arrest, DNA repair and apoptosis (reviewed 
in Shiloh, 2003; Stucki and Jackson, 2004).
Mdcl, 53BP1 and the MRN complex, constituted by the M rell, Rad50, 
and Nbsl proteins localize at nuclear foci in response to double-strand breaks. 
MRN complex have been implicated in DNA end-processing during homologous 
recombination (Trujillo et al., 1998) and possibly, but still controversially, during 
non-homologous end-joining (Di Virgilio and Gautier, 2005; Yang et al., 2006). 
In vitro as well as in vivo experiments suggest that the MRN complex may 
function as a bridge between double-strand break ends through interactions 
between the coiled-coil domains of RAD50 (Aten et al., 2004; de Jager et al., 
2001; Hopfner et al., 2002).
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Recent evidence indicates the MRN complex is an essential mediator of ATM 
recruitment to and activation by DSBs, both by forming multiple protein-protein 
contacts with ATM (Falck et al., 2005; Lee and Pauli, 2005) and by tethering 
damaged DNA, thereby increasing its local concentration (Dupre et al., 2006). 
The retention of MRN at the D SB sites requires direct binding of its Nbsl 
component to the Mediator of DNA damage checkpoint protein 1 (Mdcl) (Lee 
and Pauli, 2005; Lukas et al., 2004). Thus, both MRN complex and Mdcl, are 
crucial for the efficient activation of the intra-S phase checkpoint through the 
activation of ATM (Lukas et al., 2004; Stucki and Jackson, 2004). Mdcl proteins 
is known to increase the retention of Nbsl and 53BP1 to the sites of damage 
(Bekker-Jensen et al., 2005; Lukas et al., 2004). It is also known that Mdcl binds 
yH2AX at the site of DSBs and that the two proteins appear to function in a 
common pathway of regulation of the cellular response to DNA DSBs (Lee et al., 
2005; Stucki et al., 2005).
ATM- and Rad3-related (ATR) kinase activity is stimulated upon binding 
of the ATR-ATRIP complex to an RPA-ssDNA complex, thus making single­
stranded DNA its primary DNA damage lesion. ATR can subsequently 
phosphorylate and activate the checkpoint kinase Chkl, allowing further 
amplification of the checkpoint signal. The ATR and Chkl kinases then modify a 
variety of factors that can lead to stabilization of stalled DNA replication forks, 
inhibition of origin firing, inhibition of cell cycle progression, mobilization of 
DNA repair factors, and induction of apoptosis. It is believed that ATR is 
essential for cell survival due to its role in surveillance of DNA replication (Dupre 
et al., 2006; Zou and Elledge, 2003).
ATM and ATR are known to regulate parallel damage response signaling 
pathways. While ATM is normally activated by DNA double strand breaks, ATR
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is thought to be recruited to regions of single-stranded regions and its activation 
has been associated to the stalled replications forks (Zou and Elledge, 2003). 
Even though the two signaling pathways have been considered to function 
independently, recent studies have demonstrated that ATM functions upstream of 
ATR following exposure to ionizing radiation (IR) in S/G2 (Jazayeri et al., 2006; 
Myers and Cortez, 2006; Stiff et al., 2006).
In response to DNA damage, several components of the DNA damage 
response, which are normally found diffuse through the nucleus, are rapidly 
relocalized and concentrated into nuclear complexes that are microscopically 
detected as foci (Seno and Dynlacht, 2004; van den Bosch et al., 2003). Although 
the exact nature of the molecular processes occurring at these foci is still not 
completely understood, experimental evidence indicates that at least some of these 
foci form in correspondence or in close proximity to the sites of actual DNA 
damage and that the increase of their local concentration is beneficial for genome 
surveillance and repair (Raderschall et al., 1999; Tashiro et al., 2000). It is worth 
noting that, among the diverse modes of protein redistribution after DSB 
formation, only the proteins assembled in the DSB-flanking chromatin region on 
the ssDNA compartments has been readily detected to form intranuclear foci, thus 
foci formation cannot be used as the only criteria for the direct involvement of a 
given protein in the DSB response (Bekker-Jensen et al., 2006).
3.2.2. DNA Double stand break repair pathways
The eukaryotic cell has evolved two main mechanisms for the repair of 
DSBs: the potentially error-free homologous recombination (HR) pathway and the 
error-prone non-homologous end-joining (NHEJ) pathway (Jeggo and Lobrich,
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2006; O'Driscoll and Jeggo, 2006). A third pathway called single-strand annealing 
(SSA) is considered to be a variant of HR (van den Bosch et al., 2002). The 
choice of which pathway should be activated may depend on whether the 
damaged DNA region has already been replicated and on the precise nature of the 
break. NHEJ functions at all stages of the cell cycle, but plays the predominant 
role in both the G l- and in S-phase in regions of DNA that have not yet been 
replicated. HR functions primarily in repairing both one-sided DSBs that arise at 
DNA replication forks and two-sided DSBs arising in S or G2-phase in chromatid 
regions that have been replicated (O’Driscoll and Jeggo, 2006; Rothkamm et al., 
2003)
3.2.2.I. DNA repair by homologous recombination
Homologous recombination (HR) repair acts on DSBs occurring within 
replicated DNA (replication-independent DSBs) or on DSBs that are generated at 
broken replication forks (replication-dependent DSBs). This pathway involves 
processing of the ends of the DNA double-strand break, homologous DNA 
pairing, strand exchange, repair DNA synthesis, and resolution o f the 
heteroduplex molecules. A large number of proteins are known to be involved in 
this process; among them there are, Rad51B, Rad51C, Rad51D, Rad52, Rad54B, 
Rad54L, XRCC2, XRCC3, BRCA1, and BRCA2 (Symington, 2002).
One of the first events during homologous recombination repair is the 
resection of the DNA around the break point. This process generates tracks of 
ssDNA overhangs. It is believed that Mrel 1 nuclease activity is required in this 
process; however, there is not a general agreement about this point, since in vitro 
studies have shown that the Mrel 1 protein posseses a 3' to 5' nuclease activity,
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while the resection would require nuclease activity working in the opposite 
direction (from 5' to 3'). These findings, however, do not rule out the possibility 
that M rell may show a different enzymatic activity in vivo or that the MRN 
complex may recruit other nucleases with a suitable activity (Wyman et al., 2004). 
Rad51 protein binds to the DNA overhangs, probably after displacing RPA 
proteins. This initial binding is followed by the recruitment of other proteins such 
as Rad52 and Rad54 and by searching for homologous sequences to be used as 
template for the repair of the damaged region. This process is followed by 
invasion of the damaged strand into the homologous sequence. The 3' end then 
works as primer for DNA synthesis that makes a copy of the template. The last 
step requires the resolution of a so called, Holliday junction, with or without a 
crossover (Sung and Klein, 2006; Symington, 2002) (see Figure 3.6).
3.2.2.2. Non-homologous end-joining.
The NHEJ pathway is initiated in response to the formation of a DNA 
double-strand break (DSB) induced by a DNA-damaging agent such as ionizing 
radiation. First, the Ku70/80 heterodimer binds the ends of the DSB. The 
catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) is then 
recruited to DNA-bound Ku protein to form the DNA-PK holoenzyme. The ends 
of the break are brought together as soon as two molecules of DNA-PK (one at 
each end of the break) are joined in a synaptic complex. Other factors, such as 
polynucleotide kinase (PNK), Artemis, the MRN complex, hTdpl or the Werner 
Syndrome protein (WRN) may be required for processing the DNA ends prior to 
end rejoining (Collis et al., 2005; Jeggo and Lobrich, 2005); however, the precise 
timing of these events is not known. Following the formation o f the synaptic
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complex, the XLF/Cernunnos (Ahnesorg et al., 2006; Revy et al., 2006), XRCC4, 
DNA ligase IV proteins are recruited. Prior to end rejoining, protein factors must 
be removed from the DNA. This may involve DNA-PK autophosphorylation. At 
the final stage, the DNA ends are ligated and the DNA is repaired. (Cahill et al., 
2006; Sekiguchi and Ferguson, 2006) (see Figure 3.7).
3.2.2.3. Single strand annealing.
Single strand annealing (SSA) is a process that is initiated when a double 
strand break is made between two repeated sequences oriented in the same 
direction. It requires a first step of 5' to 3' resection of both the DSB ends to 
generate long single strand overhangs, so that the complementary strands can 
anneal to each other. MRN complex is believed to be involved in this process of 
extensive resection. SSA is typically defined as a Rad51 independent, Rad52 
dependent variant of HR.
A question that is often raised is why would organisms evolve a repair 
mechanism that deletes genetic material that might be essential for survival?. One 
possible explanation is that SSA is well suited to repair DSBs that occur within 
tandem arrays of sequences. A DSB would initiate SSA resulting in a deletion 
event of redundant genes. Another consideration is that SSA is only one out of 
several mechanisms that can seal a DSB, and offers a chance to a cell to survive if 
it can not repair a DNA damage using other repair pathways (Harrison and Haber, 
2006).
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3.3. Adeno-associated virus and the DNA Repair machinery.
Despite the growing utilization of rAAV vectors for pre-clinical and 
clinical gene transfer applications, several aspects of the life cycle of both wild 
type virus and, most notably, of the recombinant vectors still remain largely 
obscure. In particular, little information is available about the processing of 
recombinant AAV DNA once the viral particles have been internalized. This is a 
topic of particular relevance considering that a relatively small number of tissues 
are permissive to rAAV transduction, despite the receptors for AAV 
internalization are widespread in most cell types in vivo (Ding et al., 2005; Perabo 
et al., 2006; Wu et al., 2006).
In cultured cells, a marked increase in rAAV transduction efficiency is 
obtained by treating cells with agents that affect genomic DNA integrity or 
metabolism, such as UV irradiation, hydroxyurea (HU), topoisomerase inhibitors 
and several chemical carcinogens (Alexander et al., 1994b; Russell et al., 1995; 
Yang et al., 1994; Zentilin et al., 2001; Zhou et al., 1999). It is believed that, a 
major effect of these treatments is the improved conversion of the input vector 
ssDNA genome into dsDNA (Ferrari et al., 1996; Fisher et al., 1996), an essential 
requisite for gene expression.
It has been reported that cells harboring mutations in genes that participate 
in DNA repair, modify wt and recombinant AAV permissivity and the way its 
genomes are processed intracellularly. In mouse smooth muscle cells defective 
for DNA-PKcs rAAV genomes do not form circular episomes, and remain mainly 
as linear monomers or form only linear concatamers (Song et al., 2001); however, 
in this study, the authors did not show a significant change in the total levels of 
gene expression when infecting mice harboring the mutation. In vitro studies
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have suggested a possible inhibitory role of DNA-PKcs on Rep dependent site- 
specific integration (Song et al., 2004).
The single-stranded nature of DNA of the AAV genomes, the presence of 
encapsidated genomes of either positive and negative polarity, and the secondary 
structure of the ITRs, make us believe that like other viruses (Sinclair et al., 2006; 
Weitzman et al., 2004), AAV genomes may be recognized by the cell as aberrant 
forms of DNA. Indeed, AAV genomes elicit a DNA damage response that does 
not depend on the expression of any viral protein (Raj et al., 2001) and resembles 
the response to an aberrant cellular DNA replication fork (Jurvansuu et al., 2005).
Human cells mutated for ATM are dramatically more permissive to rAAV 
transduction (Sanlioglu et al., 2000; Zentilin et al., 2001), suggesting that the 
DNA damage response, or at least part of it, may exert a negative effect on viral 
transduction. Another very interesting observation is that adenovirus proteins 
E4orf6 and ElB55k, which are known to increase AAV replication and rAVV 
transduction, specifically degrade p53 protein and the MRN complex (Stracker et 
al. , 2002), events that dramatically impair the capacity of the cell to activate ATM 
and to mount an effective response after DSBs induction by ionizing radiations 
(Carson et al., 2003). Herpes simplex virus 1 (HSV-1), another well recognized 
AAV helper virus has been reported to deregulate the DNA damage signal 
transduction pathway (Hadjipanayis and DeLuca, 2005; Lilley et al., 2005; 
Wilkinson and Weller, 2006).
AAV Rep proteins are also known to interact with several cellular 
proteins, possibly affecting how the cell reacts to the presence of the AAV 
genomes. One example of this interaction is the reported direct binding between 
Rep78 and Cdc25A. This interaction presumably increases Cdc25A abundance
and prevents access to its substrates cyclin-dependent kinase (Cdk)l and Cdk2 
(Berthet et al., 2005). It has also been reported that Rep68 and 78 expression 
induces DSBs that trigger the formation of y-H2AX foci (Berthet et al., 2005). 
This observation has raised the possibility that permissivity to rAAV transduction 
might be related to the induction of cellular DNA damage response (DDR) 
mechanisms. Consistent with this notion, a few years ago we observed that, after 
transduction, rAAV genomes physically interact with some proteins involved in 
the DNA double strand break (DSB) repair, in particular Rad52 and Ku86 
(Zentilin et al., 2001). The presence of Rad52 protein in the rAVV genomes 
correlated with increased vector transduction efficiency. Recent reports have 
clearly demonstrated the participation of the homologous recombination 
machinery during rAAV mediated gene targeting, a process that may be 
mechanistically similar to AAV site-specific integration (Vasileva and Jessberger, 
2005; Vasileva et al., 2006).
Recent work exploiting self-complementary AAV vectors (which bypass 
the single-stranded to dsDNA conversion step) has shown that ATM and MRN 
proteins are required for genome circularization (Choi et al., 2006). Thus, it 
might be envisioned that some cellular proteins may exert different roles after 
AAV genomes are converted to dsDNA. At this stage, resolution of the secondary 
structures in the ITRs by promoting circulation or multimerization might be 
essential to allow stable maintenance of the viral genomes inside the nucleus.
The finding that the cellular DDR machinery is involved in rAAV genome 
processing is equally compatible with the possibilities that some of the DDR 
proteins might exert either a positive or a negative role on single-stranded to 
dsDNA conversion and genome processing. If cells are treated with DNA 
damaging agents, it is possible that factors, that may be positive or negative for
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AAV genome processing, transduction and site-specific integration are diverted 
from the incoming viral genomes to repair the cellular DNA.
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4. AIMS OF THE STUDY
Various experimental evidence indicate that the cellular machinery 
controlling the DNA damage response to double strand breaks has an important 
impact in the life cycle of recombinant and wild-type Adeno-associated virus.
The first aim of this study was to determine the role of the cellular factors 
involved in the DSB damage response in the process of conversion of the 
recombinant AAV genomes from single-stranded to double stranded DNA, a very 
well known limiting step for an efficient vector transduction. For this purpose, we 
developed a microscopic visualization technique that allowed us to observe and 
characterize the nuclear sites of conversion and/or accumulation of rAAV double­
stranded genomes. We used this methodology to evaluate the possible association 
of cellular factors that form repair foci upon DNA damage induction with the 
nuclear foci where dsDNA rAAV genomes accumulate
The second aim of this study was to characterize the role of the cellular 
proteins observed to colocalize with the rAAV foci, as well as of other proteins 
that participate in the homologous recombination and non-homologous end- 
joining repair pathways, in the process of efficient gene expression after 
transduction. The characterization of the cellular factors influencing this process 
could help us to understand the mechanism of cells permissivity to rAAV vectors.
The last but not the least aim of this study was to identify the cellular 
factors involved in the DNA damage response that may influence the process of 
AAV Rep dependent site-specific integration into an specific region of human 
chromosome 19.q.l3.3qter, called AAVS1. Understanding this process is of great 
relevance for the future development of viral gene therapy vectors with genome 
targeting capacity, since this property could reduce the potential risk of insertional 
mutagenesis associated with gene transfer.
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5. MATERIALS AND METHODS
5.1. Cell culture and transfection.
HeLa, MRC5 and AT5, HeLa pSuper-Retro-Mdcl and HeLa pSuper- 
Retro-LacZ cell lines were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10 % of fetal bovine serum. HeLa GFP-LacR and 
MRC5 GFP-LacR stably transfected cell lines were cultured as mentioned above 
in the presence of 300 pg/ml and 100 pg/ml of hygromycin. HeLa GFP- 
LacR/ElB55k and HeLa GFP-LacR/H3 54 cells clones were cultured in the 
presence of 1 pg/mL of puromycin.
Cell were transfected with siRNAs using Gene Silencer reagent 
(Genlantis, San Diego, CA, USA) according to the manufacturer’s procedure. 
DNA was transfected using Effectene transfection reagent (QIAGEN) following 
manufacturer’s protocol.
5.2. Plasmids and production of stably transfected cell line.
To produce the pAAV-Lac0.14 vector the following procedure was 
followed: the plasmid p3’ssdEGFP, which expresses GFP linked to the Lac 
repressor (LacR) and containing a nuclear localization signal, and pSV2dhfr 8.32 
which contains 10 kb of 292-bp lac operator repeat (LacO) were kindly provided 
by A.S. Belmont (University of Illinois at Urbana-Champaign). The plasmid 
pCMV-MCS (Stratagene, La Jolla, CA, USA) was digested with Not I to excise 
the multiple cloning site and substitute it with a multiple cloning site containing 
Not I, Sal I, Eco RI, Xho I, Bam HI, and Not I to obtain plasmid pMCS3’. The 
292 LacO repeat, obtained digesting pSV2dhfr 8.32 with Eco RI, was cloned into 
the Eco RI site of pMCS3’; the 8-mer repeat was then amplified by directional
cloning (Robinett et al., 1996) to obtain a vector containing 14 LacO repeats, for a 
total of 112 LacR binding sites. The 14 LacO repeats were cloned into the Not I 
site of pAAV-MCS to generate pAAV-LacO.14. To obtain stable clones 
expressing the LacR fused to GFP, HeLa and MRC5 cells were transfected with 
polyfect transfection reagent (Qiagen GmbH, Hilden, Germany) and clones were 
selected with hygromycin (300 pg/ml for HeLa cells; 100 pg/ml for MRC5 cells).
pRep-GFP plasmid was constructed as follows: AAV wild type (wt) Rep 
gene was amplified by PCR from the wtAAV molecular clone pSub201 plasmid 
(kindly provided by J. Samulski, Chapel Hill, North Carolina, USA) (Samulski et 
al., 1987). Forward primer contained the original found restriction enzyme site for 
Xba I cleavage, reverse primer was synthesized to introduce a new Sma I and Xba 
I sites, required for the following step of cloning. The primer sequences are the 
following: forward primer R201F 5VCTAGACCCGGGGTCTTATTCCTTCAC 
AGAGAGTGTCC-3' and reverse primer R201R 5' -T CG AGGAC ACT C 
T CT GT G AAGG AAT AAG ACCCCGGGT -3'. PCR amplified fragment 
containing the Rep genes was purified and cut with Xba I restriction enzyme and 
cloned in a pUG7 cloning vector previously digested with the same restriction 
enzyme. DNA sequencing of the insert was conducted to verily its fidelity in 
comparison to the pSub201 sequence provided by J. Samulski. pUG7 containing 
wtAAV Rep gene was digested with Sma I restriction enzyme and blunted (using 
T4 DNA polymerase) Ase I and Afl II excised DNA fragment from pEGFP-Nl 
was inserted (Strategene, Accession number U55762). The excised fragment 
contained the Cytomegalovirus (CMV) promoter, the Enhanced Green 
Fluorescent proteins (EGFP) and the SV40 polyadenylation site. Orientation of 
the EGFP expression cassette was verified by digestion with Xba I and Nde I 
restriction enzymes. pUG7 vector containing wt AAV Rep and EGFP expression
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cassette was digested with Xba I restriction enzyme, the 3.7 kbp fragment 
containing Rep and EGFP genes was cloned in place of the Rep-Cap sequence 
(flanked by Xba I sites) of pSub201. In this way we generated a plasmid 
containing the sequence of the inverted terminal repeats (ITRs) of wt AAV and a 
wt Rep and EGFP expression cassette. We named this plasmid pRep-GFP.
GFP-LacR/ElB55k and GFP-LacR/H354 HeLa derived cells lines were 
kindly provided by M.D. Weitzman (San Diego, California, USA).
5.3. Production of rAAV stocks.
The rAAV vectors used in this study were produced from pTR-UF5 
(AAV-GFP), kindly provided by N. Muzyczka (University of Florida, 
Gainesville, FL), pAAV-LacZ (Stratagene), pRep-GFP, and pAAV-LacO.14. 
Cloning and propagation of AAV plasmids was carried in XL-10 Gold E. coli 
strain (Stratagene, La Jolla, CA, USA). Infectious AAV vector particles were 
generated in 293 cells, using a dual plasmid cotransfection procedure with pDG as 
packaging helper plasmid (kindly provided by J.A. Kleinschmidt, Heidelberg, 
Germany) and the viral vector plasmid as previously described (Zentilin et al.,
2001). Titration of AAV-GFP and AAV-LacZ viral particles was performed by 
real time PCR quantification of the number of viral genomes, as described 
(Zentilin et al., 2001); the viral preparations used in this work had titers between 
lx l0 11 and lx l 012 viral genome particles (vgp) per ml. The titers of AAV- 
LacO.14 were measured by Southern blotting using serial dilutions of the input 
pMCS3Tac0.14 plasmid as a standard; the preparations of this vector had titers
O Q
between 1x10 and 1x10 viral genome particles (vgp) per ml.
5.4. Vector transduction.
Transduction with AAV-GFP was performed by plating 4x10s cells in 24- 
well plates. In the experiments with AAV-LacO.14, 2xl04 cells were seeded 24 h 
before vector addition in 8-well chamber slides (Labtech International, Woodside, 
UK) or in 6-cm glass bottom slides. Transduction with AAV-LacZ was 
performed in 96-well plates with 3x10 cells per well. Cell treatment with HU, 
when indicated, was performed by incubating cells for 12-16 h with 1 mM HU 
(Sigma-Aldrich, St. Louis, MO, USA) before the addition of vector. Transduction 
with the different vectors was performed in DMEM additioned with 10% FCS. 
After 3 h incubation, cells were washed in PBS and fresh culture medium was 
added. Cellular GFP fluorescence was analyzed by flow cytometry using a 
FACSCalibur (Becton Dickinson, San Jose, CA, USA) 36 h after AAV-GFP 
addition. In the case of AAV-LacZ transduction p-galactosidase activity was 
determined 36 h post-infection by measuring o-nitrophenyl-D-galacto-pyranoside 
(ONPG) cleavage using a photometric assay, as described elsewhere (Brown et 
al., 2000). Relative light units (RLU) were expressed as the ratio between ONPG 
absorbance at 405 nm divided by the amount of proteins used in the assay (in 
ng/ml), multiplied by an arbitrary factor of 1,000. Protein content was determined 
using a BCA assay kit (Pierce Chemical. Montlucon, France)
5.5. Confocal microscopy.
Live or fixed cultures were analyzed by confocal microscopy using a 
Leica TCS-SL or Zeiss LSM 510 laser scanning microscopes. The different 
channels were detected sequentially, and the laser power and detection windows 
were adjusted for each channel to exclude overlap between different
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fluorochromes. rAAV foci location was monitored through a z-series of images. 
For live cell recording, cells plated on 6-cm glass bottom dishes were placed in a 
humidified Plexiglas chamber and maintained at 37°C and 5% CO2  throughout the 
experiment.
5.6. Immunofluorescence.
At the indicated time points post infection, cells were washed twice with 
PBS and fixed and permeabilized either with 2% paraformaldehyde in PBS for 15 
min at room temperature followed by two washes with 0.1% Triton X-100 in PBS 
or with 100% methanol at -20°C for 20 min followed by treatment with 100% 
acetone at -20°C for 20 seconds. After fixing, the cells were washed twice, and 
incubated with primary antibody for 1 h and 30 min in PBS plus 0.15% glycine 
and 0.5% BSA (PBS4) in a moist chamber at room temperature. The following 
antibodies were used: mouse anti-human Rad50 (GeneTex, San Antonio, TX, 
USA, ab89) diluted 1:200; mouse anti-human Mrel 1 (GeneTex, ab214, 12D7) 
and rabbit anti-human Nbsl (Novus Biologicals, Littleton, CO, USA, ab398, NB 
100-143), rabbit anti-Phospho-Nbsl (Ser343) (Novus Biologicals, 100-284A3) 
diluted 1:500 and, anti-Mdcl rabbit polyclonal serum (kindly provided by S.P. 
Jackson) a diluted 1:200. Cells were incubated with the secondary antibodies for 1 
h in PBS+ in a moist chamber at room temperature. The secondary antibodies 
used were goat anti-rabbit Alexa 594-conjugated and goat anti-mouse Alexa 594- 
conjugated (Molecular Probes, Eugene, OR, USA) both diluted 1:1000. Chamber 
slides were mounted in Vectashield Mounting Medium (Vector Laboratories, 
Burlingame, CA, USA) containing 4’ -6’-diamino-2-phenylidole (DAPI). Fixed
cells were analyzed by fluorescence microscope with a Leica DMLB connected to 
Leica DC camera or by confocal microscopy.
5.7. RNA interference.
Cells (4x105) were plated in 35 cm dishes and transfected using 
GeneSilencer (Gene Therapy Systems, San Diego, CA, USA) according to the 
manufacturer’s recommendations. The sequence of the siRNAs against H2AX, 
Mdcl, Nsbl, Rad52, DNA-PKcs and Luciferase are indicated in table MM1. All 
siRNA duplexes were ordered from Dharmacon (Dharmacon, Lafayette, CO, 
USA).
Twenty-four hours after siRNA transfection, cells well trypsinized and 
replated in 24-well plates, 96-well plates or 8 well-chambered slides and 
transduced with rAAV.
The pSR-Mdcl cell line is a HeLa cell derivative transduced with the 
pSUPER-retro retroviral vector (pSR) (Brummelkamp et al., 2002) stably 
expressing an anti-Mdcl shRNA (insert sequence: GATCCCCGTCTCC 
C AGAAG AC AGT GATT C AAG AG AT C ACT GT CTT CT GGGAGACTTTTT GG 
AAA). The control pSR-LacZ cell line expresses an anti-(3-galactosidase shRNA 
(insert sequence: AGCTTTTCCAAAAAGTCTCCCAGAAGACAGTGATCTCT 
TGAATCACTGTCTTCTGGGAGACGGG) from the same vector. Both cell 
lines were kindly provided by Y. Shiloh (Tel Aviv, Israel)
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Table 5.1. List of synthetic siRNAs
Targeted gene Sequence Reference
H2AX C AACAAG AAG ACG CG AAU C(dTdT) (Lukas et al., 2004)
Mdcl CAACAAGAAGACGCGAAUC(dTdT) (Stewart et al., 2003)
Nbsl GGAAGAAACGUGAACUCAA(dTdT) Provided by J. Falck*
Rad52 AGACUACCUGAGAUCACUA(dTdT) (Lau et al., 2004)
DNA-PKcs GAUCGCACCUUACUCUGUU(dTdT) (Peng et al., 2002)
Firelfy Luciferase CGUACGCGG AAUACUU CG A(dT dT) Dharmacon, Inc
* Institute o f Cancer Biology, Copenhagen, Denmark
5.8. Western blotting
Total cell lysates were prepared from cells treated with siRNA. Cells were 
lysed with sample buffer (20 mM TrisHCl pH8, 20 mM NaCl, 10% glycerol, 1% 
NP40, 10 mM EDTA, 2 mM PMSF, leupeptin 2.5 pg/ml, pepstatin 2.5 pg/ml) 
followed by heating to 100°C for 5 min. Protein concentration was determined by 
the Bradford method (BioRad, Richmond, CA); 10 pg of protein per lane were 
loaded on 12% SDS-PAGE minigels, and transferred to nitro-cellulose 
(Amersham Biosciences, Bucks, UK). Immunoblots were blocked in 5% non-fat 
dry milk in TBST (50 mM TrisHCl pH 7.4, 200 mM NaCl, 0.04 % Tween 20). 
Primary antibodies anti-a-tubulin (Sigma) (diluted 1:10,000), rabbit anti-Mdcl 
(diluted 1:10,000), and anti-Nbsl (Novus Biologicals), 100-143 (diluted 1:5,000), 
rabbit and Rad52 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), sc-8350 
(diluted 1:5,000), and mouse monoclonal antibody against DNA-PKcs (Santa 
Cruz Biotechnology), sc-5282 (diluted 1:5,000), mouse monoclonal anti-M rell 
(Genetex, San Antonio, TX, USA) 12D7 (diluted 1:2,000), mouse monoclonal 
anti-Rad50 (Genetex), 13B3 (diluted 1:4,000), mouse monoclonal Elb55K (gift 
from A. Levine), B-6 (diluted 1:5,000)
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Secondary antibodies were goat anti-rabbit-IgG and goat anti-mouse-IgG 
horseradish peroxidase-labeled (DAKO, Glostrup, Denmark), 1:1,000. Secondary 
antibody detection was performed using ECL chemiluminescence system 
(Amersham Biosciences).
5.9. Real-time PCR quantification of AAV site-specific integration.
Targeted integration of AAV-Rep-GFP into AAVS1 of human 
chromosome 19 (chr-19) was detected by real-time PCR at virus-cellular 
junctions. A two-step PCR assay was established as follows. Purified genomic 
DNA samples (1 pg) were preamplified (13 cycles in Applied Biosystems 
GeneAmp PCR System 2700), in a final volume 50pL in IX polymerase buffer 
containing 2.5 U of Platinum Taq polymerase (Invitrogen, Carlsbad, CA, USA), 
200pM of each of the four deoxynucleoside triphosphate, 1.5 mM MgCl2 , 200 nM 
of primer PAAVS1 (S’-TCAGAGGACATCACGTG-S ’) (1593-1609nt of AAVS1 
accession , # S51329) and 200 nM of primer PITR (5'-
TTAACTACAAGGAACCCCTA-3') previously described by (Huser et al.,
2002). These primers are located outside the sequence region where the majority 
of published junction breakpoints have been mapped (Huser et al., 2002)Thus, 
most integration events should be detected. Assay conditions were as follows: 
95°C for 5 min (hot start); 13 cycles at 94°C for 1 min, 56°C for 1 min, and 72°C 
for 3 min; and then a final elongation step of 72°C for 15 min. A real-time 
Taqman PCR was then performed with 2 pL aliquots from the first PCR diluted in 
a final reaction volume of 25 pL. The reaction mixture included Taq polymerase 
(SIGMA JumpStart Taq ReadyMix, Sigma-Aldrich, Steinhelm, Gemamy), 1.5 
mM MgCh, 500 nM primer PAAVS1, 500 nM primer PITR, 400 nM of Taqman
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probe 6-FAM-CACTCCCTCTTCCC-MGB) complementary to AAVS1 sequence 
1513-1526nt (AAVS1 accession number S51329). Amplification conditions were 
50°C for 2 min, and 95°C for 10 min, and 45 cycles of 95°C for 1 min, 56°C for 1 
min, and 60°C for 3 min (ABI Prism 7000 Sequence detection System). The 
number of integration events was calculated by linear regression of the Threshold 
Cycle (CT) and the concentration (expressed as number of molecules) of a 
standard curve of known concentrations of the plasmid pAAVSl-TR (kindly 
provided by R. Heilbronn, Berlin, Germany)
5.10. Cell cycle profiling
All of the cells in the plates including cells floating in the medium and 
released during PBS washes were collected and analyzed. Adherent cells were 
released from the plastic by mild treatment with trypsin. Cells were washed in 
twice with PBS and resuspended in PBS containing 0.1% of NP40, RNase A (2 
pg/ml) and propidium iodide (5 pg/ml) were added and incubated for 30 minutes 
at 37°C. Samples were analyzed with a FACScan (Becton Dickinson). Data were 
analyzed with ModFit LT software (Verity Software House, Topham, ME).
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6. RESULTS
6.1. Interaction between recombinant Adeno-associated virus (rAAV) and 
cellular DNA proteins: effect on vector transduction.
The single-stranded DNA nature of recombinant AAV entails that the 
incoming genomes, once in the nucleus, must be converted into a transcriptionally 
competent double-stranded template. This process relies on the molecular 
machinery of the host cell.
Despite several recent advances, the molecular determinants that govern 
AAV genome processing are still not completely understood. Since this step 
represents one of the major roadblocks that limit the vector efficiency (Ferrari et 
al., 1996; Fisher et al., 1996), the comprehension of the biological events that 
determine the fate of rAAV DNA in the target host cells is fundamental for future 
technical improvement of AAV based gene delivery vector technology.
6.1.1. Visualization of the nuclear sites of double-stranded AAV DNA 
formation in live cells.
To better address the study of the kinetics of cell transduction with rAAV 
and, most notably, to visualize the dsDNA vector genomes in living cells, we 
constructed a recombinant AAV vector (AAV-LacO.14), carrying 112 Lac 
repressor (LacR) binding sites (LacO repeats) cloned between the viral ITRs (see 
Materials and Methods section 5.2); this vector was used to infect HeLa and 
MRC5 cell lines that stably express a GFP-LacR fusion protein with a C-terminal 
nuclear localization signal (HeLa/GFP-LacR and MRC5/GFP-LacR cells). The 
rationale of this approach is that the fluorescent sequence-specific DNA binding 
protein only binds its target sites when these are present in a dsDNA form, thus
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allowing the dynamic visualization of dsDNA formation over time (Figure 6.1 A). 
We found that the generation of double-stranded rAAV DNA was not diffuse 
throughout the nucleus but appeared restricted to specific nuclear sites, 
resembling the AAV foci originally detected by FISH by our group (data not 
shown) and other groups (Weitzman et al., 1996; Wistuba et al., 1997). Snapshots 
of a live imaging time courses of MRC5/GFP-LacR cells infected with AAV- 
LaO.14 are shown in Figure 6.IB. These foci were detected as early as 3 hours 
post infection as tiny bright spots within the diffuse GFP-LacR background signal 
inside the nucleus and then expanded into larger structures over time. The 
percentage of cells showing AAV foci increased during the first 24 hours post­
infection in both untreated and HU-treated cells and decreased at later time points 
(Figure 6.1C); at all times, the percentage of cells with AAV foci was higher after 
HU treatment (25.1±9.2% and 11.9±0.6% in HU-treated and untreated cells 
respectively at 24 hours).
The number of AAV-LacO.14 foci per nucleus was also determined in 
3D-images from 30 to 60 nuclei observed over time (Figure 6.ID). The maximum 
number of foci was detected at 24 hours post-infection in HU-treated cells 
(23.9±19.1 foci per nucleus) and at 8 hours in the untreated ells (12.1±9.6). 
Interestingly, the number of AAV foci was only modestly increased at these times 
as compared to the earlier time points, most likely suggesting that their number 
per cell was determined very early after infection. Finally, AAV foci 
progressively disappeared at longer time points, even if some foci were found to 
persist as long as 6 days in both HU-treated and untreated cells (data not shown).
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A . pAAV-LacO.14 contains the AAV ITRs flanking 14 copies o f the Lac operator sequence cassette 
(LacO), containing a total o f 112 LacR binding sites. Inside the cells, the GFP-LacR binding protein 
only binds the vector genome after its conversion to dsDNA.
B. Selected images from a time-lapse series of an individual MRC5/GFP-LacR cell, treated with HU 
and observed from 3 to 28 hr post infection. The location of AAV foci was monitored through a z-series 
o f images. Along the z a x is , nuclei were captured at 0.25 pm interval, and the fin al images were 
obtained by projection of the individual sections.
C and D. MRC5/GFP-LacR were transduced with AAV-LacO.14 either without or after treatment with 
HU. Live cells were analyzed at different times post-infection by counting the number o f cells 
displaying AAV foci (C) and the number of foci per cell (D ). The mean±s.d. o f 30-60 cells per time 
point are shown.
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6.1.2. Characterization of dsDNA recombinant AAV foci.
Detailed characterization about the fluorescence intensity and relative 
movement of this newly identified rAVV foci was conducted by Tiziana Cervelli 
(Scuola Normale di Pisa, Pisa, Italy) and is described in a coauthored manuscript 
submitted for publication (Cervelli, et al, manuscript under review, Journal of 
Cell Science).
6.1.3. rAAV foci form in close proximity with cellular M rell-Rad50-N bsl 
(MRN) complex repair foci.
Given the single stranded nature of AAV genomes and the existence of 
regions of secondary DNA structure such as the viral ITRs within the vectors, we 
wanted to establish whether a relationship existed between the formation of AAV 
foci and the localization of cellular proteins involved in the recognition and repair 
of DNA damage. One of the cellular factors that are first recruited to the site of 
DNA damage and that can bind hairpin-structured DNA is the MRN complex, 
composed by the M rell, Rad50 and Nbsl proteins. This complex binds single­
stranded and dsDNA and has a pivotal role in sensing, processing and repairing 
DSBs (D'Amours and Jackson, 2002; Petrini and Stracker, 2003; van den Bosch et 
al., 2003). To study the spatial relationship between MRN proteins and rAAV 
foci in the nucleus of transduced cells, we simultaneously visualized GFP 
fluorescence and immunostained the MRN proteins in MRC/GFP-LacR and 
HeLa/GFP-LacR cells at different times after transduction with AAV-LacO.14.
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Figure 6.2. Colocalization of AAV foci Nsbl and Phospho-Serine 343 Nsbl foci.
M RC/GFP-LacR cells were transduced with AAV-LacO.14 and then im m unostained at the indicated 
time points with anti-Nbsl (A), and anti-P-S343-N bsl (B). HU: cells were treated with hydroxyurea (1 
mM overnight) prior to AAV-LacO.14 transduction. NT: non treated
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Figure 6.3. Colocalization of AAV foci with M rell and Rad50 foci.
Hela/GFP-LacR or M RC/GFP-LacR cells, as indicated, were treated with 1 mM HU, transduced with 
AAV-LacO.14 and then immunostained at the indicated tim e points with anti-M rel 1 (A), anti-Rad50 
(B). HU: cells were treated with hydroxyurea (1 mM overnight) prior to A AV-LacO.14 transduction .
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In the absence of DNA damaging agents, MRN complex proteins had a 
predominantly diffused nuclear localization; MRN repair foci were detectable 
only in a few cells (<3%). The presence of repair foci in the cells not treated with 
HU may be associated with spontaneous and cellular DNA replication damage 
(Bekker-Jensen et al., 2006; Robison et al., 2004). However, when repair foci 
was present, we observed colocalization or close proximity of the Nbsl foci and 
the AAV-Lac.014 foci (Figure 6.2). After HU treatment, the number of cells 
with both AAV and Nbsl foci was greatly increased and the two nuclear 
structures partially co-localize also at earlier time points after transduction (shown 
at 8 and 24 hours in Figure 6.2). Notably, in both untreated and HU-treated cells, 
rAAV foci co-localized with Nbsl phosphorylated at serine 343, a marker of 
protein activation after DNA damage (Figure 6.2B) (Gatei et al., 2000; Lim et al., 
2000; Wu et al., 2000).
The same visualization experiments were also performed to detect Mrel 1 
and Rad50 proteins. In both MRC5 and HeLa cells, the vast majority of the foci 
formed by M rell and Rad50 proteins after HU treatment were found to co- 
localize or to be spatially juxtaposed to AAV foci at both 8 and 24 hours after 
transduction for M rell and, 4 and 24 hour after transduction for Rad50 (Figures 
6.3A and 6.3B).
6.1.4. Nbsl inhibits the formation of dsDNA rAAV foci.
In order to understand the functional relevance of the MRN colocalization 
with the rAAV foci, we performed silencing of Nbsl proteins using siRNA 
technology. Nbsl protein levels were decreased to less than 20% in HeLa/GFP- 
LacR cells transfected with an siRNA against the Nbsl mRNA (siNbsl) (Figure
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6.4A), when compared with cells treated with a control siRNA against Luciferase 
(siLuc) or Mock transfected cells. After effective siRNA mediated silencing of 
Nbsl, we infected cells with the AAV-LacO.14 vector (see Materials and Methods 
section 5.4 for detailed experimental procedure) and counted the number of cells 
containing rAAV foci and the number of foci per cell at 16 and 24 hours post 
infection (p.i) with or without HU treatment.
After Nbsl silencing, the number of cells with rAAV foci was markedly 
increased as compared to control cells treated with an unrelated siRNA against 
luciferase. This increase in the number of cells with foci was evident at both 16 h 
and 24 h after transduction and in the presence or absence of HU treatment 
(Figure 6.4C). At 24 h after transduction and in the absence of HU treatment, 
there were 41.08±9.93% of cells with foci when treated with anti-Nbsl siRNA, in 
comparison with 10.35±4.75% of cells with foci when treated with the control 
siRNA (representative images are shown in Figure 6.4B). Of interest, the effect 
of HU on the number of cells with rAAV foci was less pronounced at 24 h after 
transduction as compared to 16 h (1.26 fold increase in the number of foci upon 
HU treatment at 24 h, 3.19 fold increase at 16 h), indicating that the mechanism 
by which HU induces rAAV foci formation is saturable when Nbsl is knocked 
down.
In contrast to the number of cells showing rAAV foci, the total number of 
foci per cell, which had quite an ample range similar to that observed in MRG5 
cells (Figure 6.ID), was less sensitive to either HU treatment or Nbsl knock down 
(7.85±7.78 and 4.05±8.17 foci in the Nbsl and luciferase silencing, respectively, 
in the absence of HU; 4.88±4.35 and 3.05±3.34 foci in the Nbsl and luciferase 
silencing respectively, in the presence of HU at 24 h post-infection). These 
results reinforce the notion that both Nbsl and HU act by increasing the efficiency
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and kinetics of rAAV formation but do not significantly alter the frequency at 
which these structures are formed and that Nbsl play an inhibitory role at the 
level of single-stranded to dsDNA conversion and accumulation into the rAAV 
foci.
6.1.5. Nbsl inhibits rAAV transduction.
HeLa and MRC5 cell lines were infected with a rAAV vector coding for 
B-galactosidase (AAV-LacZ) and transduction efficiency was determined by 13- 
galactosidase enzymatic activity. In both cases, HeLa and MRC5 cells in which 
the Nbsl gene was silenced were significantly more permissive to AAV 
transduction at all tested MOIs (Figure 6.5). Cells treated with HU showed a 
higher level of transduction when compared with control siLuc transfected cells. 
In particular, in the case of MRC5 cells, there was a gradual increase in the 
relative difference or fold increase between cells where Nbsl was silenced in 
comparison with control cells at higher MOIs. This observation indicates that 
Nbsl plays an inhibitory role at the level rAAV transduction and that permissivity 
to functional AAV transduction correlates with the number of cells with AAV 
foci, and thus with the level of dsDNA genomes inside the cell's nucleus.
6.1.6. Nbsl inhibitory role on rAAV transduction requires ATM function.
AT5 cells, that do not express a functional ATM protein, are known to be 
highly permissive to rAAV transduction and thus to respond only minimally to 
hydroxyurea treatment (Zentilin et al., 2001) (see also Figure 6.6A). We 
hypothesized that the high permissivity to rAAV of ATM(-/-) cells, that we 
previously described, may be due to an intrinsic inability of these cells to activate
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cellular target proteins downstream ATM, like Nbsl, that may exert an inhibitory 
effect on AAV transduction. In AT5 cells, Nbsl silencing had minimal or no 
effect on the efficiency of rAAV transduction, using a broad range of MOIs of the 
AAV-LacZ vector (Figure 6.6B). These results suggest that the negative role of 
Nbsl protein on AAV transduction might require functional ATM activity.
6.1.7. Adenovirus E4orf6 and ElB55k mediated degradation of MRN 
complex increases rAAV transduction.
Productive AAV replication and rAAV transduction requires an unrelated 
helper virus, such as Adenovirus. Adenovirus ElB55k and E4orf6 proteins are 
known to enhance rAAV vector transduction and wild-type AAV replication by 
increasing the rate of conversion of the AAV genomes from single-stranded to 
dsDNA (Ferrari et al., 1996; Fisher et al., 1996), although the mechanism is 
unclear. It has been recently shown that ElB55k and E4orf6 form a complex that 
possess ubiquitin ligase activity in conjunction with cellular proteins (Harada et 
al., 2002; Querido et al., 2001) to promote degradation of cellular p53 and MRN 
complex (Carson et al., 2003; Stracker et al., 2002). Here we show that 
adenovirus ElB55k/E4orf6 mediated degradation of MRN complex correlates 
with augmentation of rAAV transduction.
We used a recombinant adenoviral vector coding for the E4orf6 to infect a 
series of HeLa stable cell clones expressing: the wild-type ElB55k and GFP- 
LacR (HeLa wtElB55k/GFP-LacR); a mutant form of ElB55k that is unable to 
associate with E4orf6 and to effectively degrade the MRN complex and GFP- 
LacR (HeLa H354/GFP-LacR); and only GFP-LacR (HeLa/GFP-LacR).
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Figure 6.4. Silencing of Nbsl increases rAAV foci formation.
A. Western blotting showing the levels o f  Nbsl in HeLa cells after treatment with siRNAs against Nbsl 
or luciferase (Luc) a t 60 h after siRNA transfection (corresponding to 24 h p.i.). The western blotting 
against tubulin is used as a loading control.
B. Representative images o f  cells treated with anti-Nbsl or anti-Luc siRNAs followed by transduction 
with AAV-GFP. The images were taken at 24 h p.i. in the absence (NT) and after HU treatment.
C. Percentage of  HeLa cells with detectable AAVLacO.14 foci after silencing o f  Nbsl or treatment with 
control siRNA against Luc.
D. Number o f  AAVLacO. 14 foci per cell after silencing o f  N bsl or treatment with control siRNA 
against Luc.
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Figure 6.5. Silencing of Nbsl increases rAAV transduction.
A. B-gal enzymatic activity measured as relative light units (RLU) in lysates from MRC5 cells after 
treatment with siRNAs against Nbsl (siNbsl) or against the control gene luciferase (siLuc), followed by 
transduction with AAV-LacZ.
B. Same as in panel A in HeLa cells.
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Figure 6.6. AT5 cells are more permissive to rAAV and Nbsl inhibition role requires ATM  
function.
A. (3-gal enzymatic activity measured as relative light units (RLU) in lysates from AT5 and cells after 
transduction with AAV-LacZ.
B. B-gal enzymatic activity measured as relative light units (RLU) in lysates from AT5 cells after 
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transduction with AAV-LacZ.
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Figure 6.7. Adenovirus E4orf6/Elb55k mediated degradation of MRN complex increases rAAV 
transduction.
A. HeLa-derived cell lines expressing GFP-LacR or GFP-LacR with E lb55K  or mutant H354 proteins 
were analyzed by w estern immunoblotting for E lb 5 5 K  expression and degradation o f  the M re l l  
complex in the presence o f  E4orf6.
B. B-gal enzymatic activity measured as relative light units (RLU) in lysates HeLa-derived cells lines 
expressing GFP-LacR or GFP-LacR with E lB 55k  or mutant H354 after transduction with AAV-LacZ .
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As expected, degradation of M rell protein and partial degradation of 
Rad50 was only observed when wtElB55k and E4orf6 proteins were expressed in 
the same cells (Figure 6.7A). When these cells were additionally infected with 
rAAV-LacZ and B-galactosidase activity was measured, we observed a dramatic 
increase in the level of transduction in the cells where MRN complex was 
degraded (Figure 6.7B). This increase in transduction was not observed in cells 
infected with rAd-E4orf6 and expressing the H354 mutant ElB55k. These results 
correlate Mrel l degradation with enhanced rAAV transduction, and suggest that 
the Mrel l complex negatively impacts rAAV transduction. A more detailed 
characterization of this correlation is shown in a coauthored manuscript with the 
M.D. Weitzman group (Schwartz et al, manuscript under revision, EMBO 
reports).
6.1.8. ElB55k/E4orf6 mediated degradation of MRN complex correlates with 
increased num ber of cells with dsDNA rAAV foci.
In order to see if transduction efficiency of rAAV correlates with the 
formation of double stranded rAAV DNA genomes, we treated wtElB/GFP- 
LacR, H354/GFP-LacR, and GFP-LacR HeLa cell clones with rAd-E4orf6 and 
then infected them with AAV-LacO 14 vector. As expected, cells expressing 
simultaneously wtElB55k and E4orf6 showed an increase in the number of cells 
with rAAV foci, that represent sites of accumulation of vector dsDNA, when 
compared with the same cell lines not infected with rAd-E4-orf6 (from 7.9±0.8% 
to 59.3±5.6%). HeLa H354/GFP-LacR cell line infected rAdE4orf6 showed a 
higher number of cells with foci in comparison to the same cell line not infected 
with rAd (from 6.4±1.3% to 19.5±5.8%) (Figures 6.8A and 6.8B). On the
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contrary, in the cell line expressing just GFP-LacR we detected only a basal 
number of cells with AAV foci, that were about 4.4±2.0% and 3.8±1.3% in the 
presence or absence of infection with rAdE4orf6 respectively. These results 
together show, that ElB55k/E4orf6-mediated degradation of the MRN complex 
increases rAAV foci formation and transduction, suggesting again that the MRN 
complex may play an inhibitory role at the level of single-stranded to dsDNA 
rAAV genome conversion. ElB55k/E4orf6-mediated degradation of the MRN 
complex did not affected in a statistically significant manner the number of rAAV 
foci per cell (Figure 6.8C).
6.1.9. AAV foci form in close proximity of Mdcl foci.
The Mdcl protein is known to control cellular responses to DNA damage, in part 
by interacting with the MRN complex and, more specifically, by mediating the 
transient interaction of Nbsl with DSBs and its phosphorylation by ATM 
(Goldberg et al., 2003; Lukas et al., 2004; Stewart et al., 2003; Xu and Stem, 
2003). In our experimental settings, AAV-LacO.14 foci were also found in close 
proximity with the foci at which the Mdcl protein accumulates, in both untreated 
cells and in cells treated with camptothecin before infection (Figure 6.9A). This 
colocalization suggests a possible role of Mdcl in the recruitment of MRN 
complex to the site of accumulation of rAAV dsDNA.
6.1.10. Silencing of Mdcl decreases rAAV transduction.
In order to quantify the extend of rAAV transduction in the absence of the 
Mdcl protein, we took advantage of the availability of stable HeLa cell clones 
containing retroviral vectors expressing a short-hairpin RNAs (shRNA) against
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Mdcl or against a control protein LacZ (Lukas et al., 2004). These cells were 
infected with a rAAV viral vector coding of the EGFP gene (AAV-GFP) and the 
efficiency of transduction was measured by FACS analysis. The cell clone in 
which Mdcl was silenced was significantly more permissive to AAV-GFP 
transduction, both in the absence or following HU treatment (Figure 6.9C). 
Similar results were obtained when HeLa cells where transiently transfected with 
synthetic siRNA against Mdcl (Figure 6.9E). The complete silencing of the 
Mdcl protein was obtained in both cases. (Figures 6.9B and 6.9D). Again, the 
increase in rAAV transduction after Mdcl silencing is in concordance with the 
idea that Mdcl may play a role in the inhibitory action of the MRN complex at 
the level of rAAV transduction.
6.1.11. Rad52 silencing results in decreased rAAV transduction efficiency.
Previous results from our laboratory indicated that the protein Rad52 binds 
to rAAV genomes and that Rad52 (-/-) fibroblasts are less permissive than wild 
type to rAAV transduction (Zentilin et al., 2001). In order to deeply investigate 
the role of this protein in determining the fate of rAAV genomes inside the 
infected cells, we transfected HeLa cells with and siRNA against Rad52. Western 
blot analysis revealed that 70-80% of reduction of the protein was obtained 48 
hour after siRNA transfection (inset of Figure 6.10A). Under these conditions, 
cells treated or untreated with HU, showed a maximum of 2,1 fold reduction in 
the fi-galacatosidase activity at a MOI of 10,000 vgp/cell, when compared with 
the cells transfected with the control siRNA against Luciferase (Figure 6.10A). 
Contrary to the effect observed after silencing of Nbsl and M dcl, Rad52 
silencing resulted in a significant decrease in vector transduction, this
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independently of HU treatment. This observation is in concordance with the 
results obtained previously and suggests a possible involvement of Rad52 protein 
in the processing or stabilization of transcriptionally active rAAV genomes.
6.1.12. DNA-PKcs silencing results in decreased rAAV transduction 
efficiency.
DNA-PKcs, a key protein in the process of double-strand break repair by 
non-homologous end-joining, has been also implicated in the determination of the 
molecular fate of rAAV genome in vivo. Studies of gene delivery on mouse 
muscle have shown that, in the presence of DNA-PKcs, rAAV DNA form circular 
episomes, while in its absence, rAAV gemomes remain as linear monomers or 
form linear concatamers (Song et al., 2001). Nevertheless, in these studies the 
levels of transgene expression in this system remained unchanged over time. In 
order to better characterize the possible role of DNA-PKcs in rAAV transduction, 
we transfected a specific siRNA in HeLa cells obtaining more than 80% reduction 
of the DNA-PKcs protein at 48 hours after treatment (inset of Figure 6.1 OB). 
Then, these cells were either treated or not with HU and infected with an AAV- 
LacZ vector. Interestingly, a significant reduction in vector transduction was only 
observed when cells were treated with HU. On the contrary, no statistically 
significant differences were observed between DNA-PKcs silenced and control 
cells when HU was not added (Figure 6.1 OB). These results suggest a possible 
participation of DNA-PKcs in rAAV processing in HeLa cells but only in the 
presence of HU induced cell damage.
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Figure 6.8. E4orf6/ElB55k mediated degradation of MRN complex correlates with an increase in 
the number of cells with rAAV foci but not the number of foci per cell.
A. HeLa cell lines expressing GFP-LacR alone or with E lb55K  or H354 m utant were, when indicated, 
infected with rAd-E4orf6 (MOI 25) for 24 hrs before super-infecting with AAV-LacO.14 (MOI 400) for 
another 16 hrs. Cells were fixed and analyzed by confocal microscopy for rAAV-LacO.14 foci.
B. Quantification o f  the number of  cells with A A V-Lac014 foci in GFP-LacR Elb55K /H 354 cell lines 
previously infected, when indicated, with rAdE4orf6. For each treatment, the average o f  3 groups o f  at 
least 120 cells each is presented. Error bars represent standard deviation o f  the mean.
C. Same as panel B but quantification o f  the number o f  foci per cell.
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Figure 6.9. Colocalization of AAV foci with M dcl foci and its silencing increases rAAV 
transduction
A. MRC/GFP-LacR cells were transduced with AAV-LacO.14 and then immunostained at 24 hour p.i. 
with anti Mdcl antibody. CPT: cells were treated with camptothecin (1 nM for 6 h) prior to AAV - 
LacO.14 transduction.
B. Levels o f  Mdcl protein in the pSR-Mdcl and pSR-LacZ HeLa derived cell clones.
C. Flow cytometry analysis o f  stable HeLa cell clones containing retroviral vectors expressing shRNAs 
against Mdcl (pSR-Mdcl) or (3-galactosidase (pSR-LacZ) after transduction with AAV-GFP.
D. Levels of  Mdcl protein 60 h after siRNA transfection (24 h after AAV-GFP transduc tion) .
E. Flow cytometry analysis o f  HeLa cells transfected with siRNAs against Mdcl or luciferase.
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Figure 6.10. rAAV transduction after Rad52, DNA-PKcs and H2AX siRNA mediated silencing.
A. B-gal enzymatic activity measured as relative light units (RLU) in lysates from HeLa cells after 
treatment with siRNAs against Rad52 (siRad52) or against the control gene luciferase (siLuc), followed 
by transduction with AAV-LacZ (MOIs o f 10,000, 5,000, 2,500, 1,000, or non-infected -  NEG). Where 
indicated, cells were treated with hydroxyurea (overnight).
B. Same as panel A with siRNA against DNA-PKcs (siDNA-PKcs) at MOIs o f 8,000, 5,000, 4,000, 
2,500, 1,000, or non-infected- NEG)
C. Same as panel A with siRNA against H2AX (siH2AX)
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6.1.13. H2AX silencing results in decreased rAAV transduction efficiency.
We silenced histone H2AX in HeLa cells by means of siRNA technology, 
before infecting them with an AAV-LacZ vector. In this case we observed results 
similar to those obtained after silencing DNA-PKcs. A significant reduction in 
transduction efficiency was observed specifically in the cells that were treated 
with HU (Figure 6.IOC). In cells that were not treated with HU there was only a 
slight reduction in rAAV transduction, with respect to the cells transfected with 
the control siRNA against Luciferase, but only at infection MOI of 10,000 
vgp/cell,. Decreasing the levels of H2AX may impair the capacity o f the cell to 
elicit a cellular response to DNA damage (Lukas et al., 2004). These results 
suggest that HU treatment in cells with decreased levels of H2AX or DNA-PKcs 
may induce the activation of pathways that play an inhibitory role on rAAV at the 
level of transduction.
6.2. Interaction between AAV Rep containing recombinant Adeno-associated 
virus (rAAV) and cellular DNA machinery: effect on vector transduction 
and site-specific integration.
In the absence of a helper virus infection, wild-type AAV, as well as viral 
vectors containing the AAV Rep gene, mainly integrate in a site-specific fashion 
in human cells (McCarty et al., 2004). Both AAV DNA replication and site- 
specific integration require the large nonstructural Rep proteins (Rep68/78) and 
specific motifs within the viral ITRs. The cellular proteins participating in the 
process of Rep-mediated site-specific integration and the molecular mechanism of 
integration itself are still largely elusive. In this task we will explore the
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hypothesis that the process might involve the cellular proteins that participate in 
the cellular DNA repair.
6.2.1. Establishment of a quantitative real-time PCR procedure for the 
determination of rAAV site-specific integration.
We have established a highly sensitive method to quantify the events of 
site-specific integration of AAV DNA into chromosome 19ql3.3qter, in the 
region named AAVS1 (Linden et al., 1996a). The system is based on a two-step, 
real-time quantitative PGR assay with primers located in the AAVS1 region on 
Chl9ql3.3qter and in the AAV ITR, as originally described by Huser, et al. 
(2002). Only the samples that contain the flanking sequences of the 3’ ITR of the 
virus and a downstream sequence of the AAVS1 region are amplified in the first 
PCR reaction and then quantified using a TaqMan probe in the second PCR 
reaction (schematic representation shown in Figure 6.11 A). Standardization of 
the protocol was carried out using control plasmid pAAVSl-ITR, constructed for 
this purpose, and genomic DNA extracted from a cell line containing site- 
specifically integrated AAV genomes. The developed technology showed a wide 
range of linearity in the determination of the number of AAV Rep-dependent site- 
specific integration events from 45 to 45x105 copies/pg of genomic DNA, as 
shown in Figure 6.1 IB. In order to rule out the possibility of unspecific 
amplification of rAAV and genomic sequences in the absence of integration at the 
AAVS1 locus, we transfected HeLa cells with a plasmid coding for the Rep68 
proteins or a control plasmid, and then infected these cells with the AAV-GFP 
(not expressing Rep) viral vector, as already suggested by others (Huttner et al., 
2003). As expected, PCR amplification was observed only in the infected cell 
samples where Rep68 protein was expressed; mock infected cells or samples
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infected with the AAV-GFP alone did not show any detectable amplification 
(Figure 6.12A).
Site-specific AAV integration requires the presence of the wtAAV Rep68 
or 78, proteins that are typically not included in the rAAV vector used in gene 
therapy and many biotechnological applications. We constructed a rAAV viral 
vector that contains the wild-type Rep open reading frame (ORF) and the EGFP 
gene in the place of the Cap ORF (AAV-Rep-GFP) (see Materials and Methods 
for detailed explanation of the construct). In this way we can evaluate the level of 
vector transduction and site-specific integration in the same samples.
Using this technology, we demonstrated that the AAV-Rep-GFP vector 
DNA integrated site-specifically into the host cell DNA at the AAVSl locus at 
frequencies that were comparable with those of the wt virus (6-7% of cells with 
site-specific integration) (Huser et al., 2002). The integration frequency was 
observed to increase in a dose-dependent manner at increasing MOIs (Figure 
6.12B). Non-detectable integration events were observed in the absence of AAV- 
Rep-GFP or after infection with AAV-GFP.
6.2.2. Silencing of Nbsl increases frequency of Rep-dependent site-specific 
integration.
We evaluated the transduction efficiency of AAV-Rep-GFP in HeLa cells 
after transfection with siRNAs against either Nsbl or Luciferase in the presence 
and absence of HU treatment.
Interestingly, we observed a small but statistically significant increase in 
transduction of AAV-Rep-GFP at a MOI of 5,000 vgp/cell with or without HU 
treatment (from 29.2±1.6% to 32±0.7% after HU, and from 22.8±0.2% to 
28.9±2.3% in the absence of HU) (Figure 6.13 A); this in agreement with the data
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already described. A remarkable finding was observed when we looked at the 
levels of vector integration at the AAVS1 region. We detected a dramatic 
increase in the level of site-specific integration after silencing of Nbsl at both 
MOI of 5,000 (8.3 fold) and 1,600 vgp/cell (15.8 fold) (Figure 6.13B). 
Interestingly, the Rep-dependent AAV site-specific integration appears to more 
closely rely on the presence of the Nbsl protein than the transduction process. 
Nevertheless, Nbsl exerts an inhibitory role at both levels.
6.2.3. Silencing of M dcl increases frequency of Rep dependent site-specific 
integration.
The same experimental procedure was used to evaluate the involvement of 
the Mdcl protein in the process of Rep-mediated AAV site-specific integration. 
HeLa cells were transfected with the siRNAs against Mdcl, or Luciferase as 
control, and then infected with AAV-Rep-GFP vector in the presence and absence 
of HU treatment. As expected, silencing of the Mdcl protein determined an 
increase in vector cell permissivity, measured as percentage of infected cells 
expressing the GFP reporter gene (from 32.8±1.0 to 37.7±0.7 with HU treatment 
at MOI=5,000, from 22.8±0.2 to 25±3 without HU treatment at MOI=5,000, and 
from 7.6±0.4 to 13.0±0.1 with HU treatment at MOI=T,600). Also in this case, the 
effect of Mdcl silencing was slightly blunted by the presence of the Rep protein 
(compare figure 6.14A and 6.9C). Nevertheless, similarly to what observed after 
Nbsl silencing, Mdcl silencing resulted in a dramatic increase (39.4 fold increase 
at MOI=5,000 and 2,649 fold increase at MOI=1,600) in the number of 
integration events at the AAVS1 locus (Figure 6.14B). All these data suggest the 
Mdcl may inhibit AAV transduction in the presence of Rep protein but more 
remarkably it inhibits AAV site-specific integration.
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A. Schematic representation o f  the real-time PCR quantification experimental procedure.
B. Cycle  number versu s Delta Rn from a representative experiment o f T  aqman real-time PCR 
amplification of  pA A VSl-TR plasmid serial dilutions (from 45 to 45x1 05 copies/ug o f  genomic DNA). 
Insert: Scattered plot o f  the number of  copies per pg o f  genomic DNA as a functions o f  the Cycle of 
threshold (CT). The number o f  copies is represented in logarithmic scale. Minimum scares fitting curve 
is plotted in red.
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Figure 6.12. Establishment of real-time PCR for the quantification of AAV site-specific 
integration: PCR Amplification of AAV and AAVS1 junctions only occur when Rep is provided.
A. Cycle  number versus Delta Rn from a representative experiment o f  Taqman real-time PCR 
amplification genomic DNA isolated from HeLa cells 48 hrs after transfection with pTR-UF5 (AAV- 
GFP) together with an AAV Rep68 expression plasmid or with the control plasmid pcDNA3, or Mock 
infected
B. Cycle number versu s Delta Rn from a representative experiment o f T  aqman real-time PCR 
amplification genomic DNA isolated from HeLa cells 48 hrs after infection with AAV-Rep-GFP vector, 
AAV-GFP vector or Mock infected.
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Figure 6.13. Effect of Nbsl silencing on AAV-Rep-GFP transduction and site-specific integration.
A. Flow cytometry analysis o f  HeLa cell after transduction with AAV-GFP. Cells were transfected with 
siRNA against N bsl (siNabsl)  or with a control siRNA against Luciferase (siLuc) and either with our 
without hydroxyurea (HU).
B. Quantification of  Rep mediated site-specific integration. Cells were transfected with siRNA against 
Nbsl (siNabsl) or with a control siRNA against Luciferase (siLuc), 48 hrs before infection with AAV- 
Rep-GFP. Number o f  integration events per ixg o f  genomic DNA is expressed in logarithmic scale. 
Transduction and s ite-specific integration experiments were conducted at M 01 o f  1,600 and 5,000 
vgp/cell.
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Figure 6.14. Effect of Mdcl silencing on AAV-Rep-GFP transduction and site-specific integration.
A. Flow cytometry analysis o f  HeLa cell after transduction with AAV-GFP. Cells were transfected with 
siRNA against Mdcl (siM dcl) or with a control siRNA against Luciferase (siLuc) and either with our 
without hydroxyurea (HU).
B. Quantification o f  Rep mediated site-specific integration. Cells were transfected with siRNA against 
Mdcl (siM dcl) or with a control siRNA against Luciferase ( s iL u c) , 48 hrs before infection with AAV- 
Rep-GFP. Number o f  integration events per pg o f  genomic DNA is expressed in logarithmic scale. 
Transduction and s ite-specific integration experiments were conducted at M 01 o f  1,600 and 5,000 
vgp/cell.
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6.2.4. Silencing of Rad52 decreases the frequency of Rep dependent site- 
specific integration.
We have shown that silencing of Rad52 protein resulted in significant 
decrease in cell permissivity to rAAV transduction (Figure 6.10A); this trend was 
also reproduced for the AAV-Rep-GFP vector (from 2.1 to 2.3 fold decrease in 
the percentage of GFP positive cells with HU pre-treatment, and from 1.7 to 1.9 
fold decrease without HU treatment), at MOIs of 5,000 and 1,600 vgp/cell (Figure 
6.15 A).
The striking observation was that we were not able to detect any 
integration of the AAV vector by real-time PCR technique at the MOIs of 5,000 
and 1,600 vgp/cell in samples in which the Rad52 protein was silenced (Figure 
6.15B). A similar reduction in integration was observed when cells where 
transfected with a pSuper plasmid coding for a hairpin siRNA against Rad52 
(pSuper-Rad52) (Figure 6.15C). Previous chromatin immunoprecipitation 
experiments conducted in our laboratory indicating that Rad52 protein interacts 
physically with rAAV genomes (Zentilin et al., 2001) prompted us to hypothesize 
that Rad52 may be directly required during AAV site-specific integration.
6.2.5. Silencing of DNA-PKcs decreases frequency of Rep-dependent site- 
specific integration.
Similar to the results obtained after evaluating the effect of Rad52 
silencing in the presence and in the absence of Rep protein, transduction of 
rAAV-Rep-GFP vector was significantly reduced after siRNA-mediated silencing 
of DNA-PKcs in HeLa cells (Figure 6.16A). This reduction was observed in cells 
both treated or not with HU at MOI=5,000 (from 32.8±0.7% to 19.5±9.3% with 
HU treatment, and from 22.8±0.2% to 15.3±0.8% without HU treatment).
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Figure 6.15. Effect of Rad52 silencing on AAV-Rep-GFP transduction and site-specific 
integration.
A. Flow cytometry analysis o f  HeLa cell after transduction with AAV-GFP. Cells were transfected with 
siRNA against Rad52 (siRad52) or with a control siRNA against Luciferase (siLuc) and either with our 
without hydroxyurea (HU). Infections were conducted at MOIs o f  1,600 and 5,000 vgp/cell.
B. Quantification o f  Rep mediated site-specific integration. Cells were transfected with siRNA against 
Rad52 (siRad52) or with a control s iRNA against Luciferase (siLuc) , 48 hrs before in fection with 
AAV-Rep-GFP. Number o f  integration events per pg o f  genomic DNA is expressed in logarithmic 
scale. <100 stands for Non-detectable. Infections were conducted at MOIs o f  1,600 and 5,000 vgp/cell.
C. Quantification of  Rep mediated site-specific integration. Cells were transfected with pSuper-Rad52 
or with a control pSuper-GFP, 48 hrs before infection with AAV-Rep-GFP. Number o f  integration 
events per pg o f  genomic DNA is expressed in logarithmic scale. Infection was conducted at a MOI o f  
1,600 vgp/cell.
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Figure 6.16. Effect of DNA-PKcs silencing on AAV-Rep-GFP transduction and s ite-specific 
integration.
A. Flow cytometry analysis o f  HeLa cell after transduction with AAV-GFP. Cells were transfected with 
siRNA against DNA-PKcs (siDNA-PKcs) or with a control siRNA against Luciferase (siLuc) and either 
with our without hydroxyurea (HU).
B. Quantification o f  Rep mediated site-specific integration. Cells were transfected with siRNA against 
DNA-PKcs (siDNA-PKcs) or with a control siRNA against Luciferase (siLuc) , 48 hrs before infection 
with AAV-Rep-GFP. Number of  integration events per pg o f  genomic DNA is expressed in logarithmic 
scale. <100 stands for Non-detectable.
Transduction and s ite-specific integration experiments were conducted at M OI o f  1,600 and 5,000 
vgp/cell.
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Previous studies have shown that DNA-PKcs may play an inhibitory role 
at the level of site-specific integration (Song et al., 2004). In disagreement with 
these findings, our results show that the siRNA-mediated silencing of DNA-PKcs 
produced a decrease in site-specific integration (Figure 6.16A). This discrepancy 
could be due the fact that Song and collaborators conducted their experiments 
using an in vitro integration assay, while additional levels of complexity might 
well be present in living cells.
6.2.6. Silencing of H2AX decreases frequency of Rep-dependent site-specific 
integration.
Parallel to what has been previously described for Rad52 and DNA-PKcs, 
silencing of the H2AX histone decreased the permissivity of the cells to AAV- 
Rep-GFP transduction, both in the presence and absence of HU treatment at a 
MOI of 5,000 vgp/cell (Figure 6.17A). At lower MOIs a difference in cells 
permissivity was not observed.
Site-specific integration at the AAVS1 locus was also reduced to the point 
of becoming undetectable, both in the cells infected with a MOI of 5,000 as well 
at a MOI of 1,600 (Figure 6.17B).
6.3. Cell cycle profile after silencing of Nbsl, Mdcl, H2AX, Rad52 and DNA- 
PKcs.
The knocking down of the proteins that are the subject of this study could 
affect the normal progression of the cell cycle. Since there is still some 
controversy about the dependence of rAAV transduction efficiency in cell culture 
on the cell cycle (Alexander et al., 1994a; Alexander et al., 1996; Russell et al., 
1995; Russell et al., 1994; Yakobson et al., 1987), we analyzed the possible
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association between a specific cell cycle profile and the differences in 
transduction of rAAV observed after silencing. There are no studies indicating 
whether AAV site-specific integration may be favored during any particular phase 
of the cell cycle, however, AAV mediated gene targeting which depends on the 
HR machinery is favored, as expected, during S-phase (Trobridge et al., 2005).
To rule out the possibility that the differences in transduction efficiency 
that we observe are due to cell cycle arrest after RNAi silencing, we transfected 
HeLa cells with siRNAs against Nsbl, Mdcl, H2AX, DNA-PKcs, and Rad52 and 
determined their cell cycle profile by FACS analysis at the moment of maximum 
silencing. The results shown in Figure 6.18 indicate that only very minor changes 
were observed after RNA silencing of any of the investigated proteins; no 
correlation could be detected between the observed cell cycle profiles and the 
extent of rAAV transduction. Cells treated with HU, irrespectively of the siRNA 
used, showed cell cycle arrest in Gl/S, as expected.
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Figure 6.17. Effect of H2AX silencing on AAV -Rep-GFP transduction and site-specific 
integration.
A. Flow cytometry analysis o f  HeLa cell after transduction with AAV-GFP. Cells were transfected with 
siRNA against H2AX (siH2AX) or with a control siRNA against Luciferase (siLuc) and either with or 
without hydroxyurea (HU).
B. Quantification o f  Rep mediated site-specific integration. Cells were transfected with siRNA against 
DNA-PKcs (siDNA-PKcs) or with a control siRNA against Luciferase (siLuc) , 48 hrs before infection 
with AAV-Rep-GFP. Number o f  integration events per pg o f  genomic DNA is expressed in logarithmic 
scale. <100 stands for Non-detectable.
Transduction and s ite-specific integration experiments were conducted at M OI o f  1,600 and 5,000 
vgp/cell.
87
NT 1 mM 
HU
H  GOGl
H  S-Phase
 j G2M
A
}—I GOGl
GOGl:
S-Phase;
G2M:
(— | G2M
I
H G O G t
j— | S-Phase
| j G2M
j— I S-Phase
X
H G0G1
[—  S-Phase
X
GOGl:
S-Phase:
G2M:
GOGl:
S-Phase:
G2M:
H Q0G1H  GOG’
|— | S-Phase[— j S-Phase
LX j G2M
— I GOG1 H  GOGl
i— | S-Phase 1—  S-Phase
I  G2M! j G2M
GOGl:
S-Phase:
G2M:
GOGl:
S-Phase:
G2M:
NT
56.85%
19.92%
23.23%
55.04%
22 .22%
22.74%
58.88%
20.57%
20.55%
61.41%
19.61%
18.98%
55.99%
21.64%
22.37%
1 mM 
HU
67.47%
21.36%
11.17%
60.47%
26.13%
13.40%
65.35%
22.81%
11.84%
! 1 GOGl 3 |—) G0G1
| . j— j S-Phase g: j— j S-Phase GOGl: 58.89% 67.07%
L 1 |------1 G2M S-Phase: 20.45% 22.10%L
~ fin : L G2M: 20.66% 10.83%
69.65%
20.08%
10.27%
62.00%
22.67%
15.33%
Figure 6.18. Cell cycle profile after siRNA mediated silencing against H2AX, Mdcl, Nsbl, Rad52 
and DNA-PKcs.
Cell cycle profile o f  HeLa cells after transfection with s iRNA against Luciferase (siLuc), H2AX 
(siH2AX), Mdcl (siMdcl), Nbdl (siNbsl) ,  Rad52 (siRad52), DNA-PKcs (siDNA-PKcs), with or 
without hydroxyurea treatment (HU and NT).
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1, DISCUSSION
7. 1. DNA Repair machinery and its influence on rAAV transduction and 
genome processing:
Despite the valuable properties of rAAV vectors for in vivo gene transfer, 
the molecular correlates of rAAV transduction are still poorly understood. Due to 
the single-stranded nature of the AAV genome, its processing into a double- 
stranded, transcriptionally active molecular species clearly represents a 
fundamental event. This notion is nourished by in vivo studies that showed that 
long-term transgene expression mediated by rAAV vector correlates with the 
formation of double-stranded, circular and concatamerized vector genomes (Duan 
et al., 1998; Schnepp et al., 2005; Yang et al., 1999).
In this study, we have exploited live imaging microscopy to assess the 
kinetics of double-stranded rAAV DNA accumulation in the nucleus of 
transduced cells, in the absence of viral replication or expression of any helper 
virus gene product. The developed system takes advantage of the interaction of a 
EGFP-LacR fusion protein, expressed at low levels in the nucleus of the 
transduced cells, with 112 repeats of the cognate LacO sequence cloned into a 
rAAV vector. Since LacR specifically binds dsDNA, this approach permits the 
visualization of rAAV genomes once converted from ssDNA to dsDNA inside the 
nucleus. By using this approach in different cell types, we observed that rAAV 
dsDNA accumulation does not occur diffusely in the nucleoplasm, but is confined 
to specific rAAV foci, which become detectable as early as 3 h after cell infection 
and progressively increase in size and intensity of fluorescence over the first 12 h 
after infection, suggestive of a progressive accumulation of viral dsDNA genomes 
into these structures. A detailed biophysical analysis of rAAV foci by time lapse 
imaging studies indicates that these nuclear structures are rather stable over time
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and are relatively immobile. Moreover, these fluorescent foci do not appear 
associated with the insoluble chromatin compartment of the nucleus, since they 
completely disappear when AAV-LacO.14 transduced cells are treated with mild 
detergents before fixation (data not shown). Given the sensitivity threshold of 
conventional fluorescence microscopy, as well as the fluorescent behavior of 
single EGFP molecules (Cinelli et al., 2000), it is clear that each of the rAAV foci 
comprises several dsDNA molecules, which might well correspond to 
multimerized rAAV genomes, as shown by a number of studies that analyzed the 
molecular nature of transcription-competent AAV genomes in the transduced cells 
(Afione et al., 1996; Flotte, 2004; Yang et al., 1999).
Cell treatment with HU is known to significantly boost the efficiency of 
rAAV transduction (Russell et al., 1995; Zentilin et al., 2001). In our 
experiments, we observed that the same treatment also increased the number of 
cells with rAAV foci, thus showing that the formation of rAAV foci positively 
correlates with the transgene transduction. Both in the presence or absence of HU 
treatment, the number of cells with rAAV foci peaked between 24 and 48 h post 
infection, and then gradually decreased. This decrease may be well due to the 
slow degradation of some rAAV genomes or to their migration out of the foci to 
the nucleoplasm.
Previous studies with wt AAV in Adenovirus-infected cells have shown, 
by immunofluorescence and in situ hybridization, that, during infection, wt AAV 
DNA replication occurs in discrete nuclear compartments (Weitzman et al., 1996; 
Wistuba et al., 1997). Similar findings have been also confirmed in live cells 
infected with HSV-1 or transfected with HSV-1 DNA, by using a rAAV vector 
containing only 40 tandem repeats of a LacO binding sites and a reporter protein 
similar to ours (Fraefel et al., 2004). The presence of these AAV foci has been
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interpreted as an indication of the existence of nuclear compartments in which 
AAV DNA replication takes place. The observation that both the Rep proteins 
and helper virus DNA also co-localized with these foci is fully consistent with this 
interpretation (Fraefel et al., 2004; Glauser et al., 2005; Weitzman et al., 1996). 
The rAAV foci we detect in our experiments might well be coincident with the 
nuclear compartments where AAV and Adenovirus replication occurs. However, 
it should be pointed out that the rAAV foci we observe are not determined by the 
presence of any expressed viral protein normally involved in replication. Instead, 
our experiments indicate the existence of specific nuclear compartments that have 
strong affinity for rAAV DNA in the absence of viral or helper proteins, and thus 
suggest that rAAV DNA is specifically recognized by cellular factors.
Indeed, we found that rAAV foci partially colocalize or are closely 
juxtaposed to the nuclear compartments where MRN complex proteins 
accumulate upon treatment of the transduced cells with HU or other DNA 
damaging agents (UV and camptothecin, data not shown). In support of the 
notion that these proteins are actively involved in a DNA repair process, we 
observed that rAAV foci associated with foci of a DNA damage-activated form of 
Nbsl, phosphorylated at serine 343, (Gatei et al., 2000; Lim et al., 2000; Wu et 
al., 2000). MRN complex is known to bind both ss and dsDNA and to possess a 
pivotal role in sensing damaged or hairpin-structured DNA (DAmours and 
Jackson, 2002; Petrini and Stracker, 2003; van den Bosch et al., 2003). In 
keeping with the possibility that the DNA double strand break repair machinery is 
involved in rAAV genome processing, we found that an upstream mediator, 
Mdcl, known to increase the retention of Nbsl at the sites of DNA damage 
(Lukas et al., 2004), also formed foci that partially colocalized with the rAAV 
foci.
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What might be the role of the MRN proteins and of Mdcl in rAAV 
genome processing? Our RNAi experiments clearly suggest that the overall effect 
of these proteins is inhibitory in rAAV dsDNA formation. Silencing of Nbsl by 
RNAi increased the number of cells containing rAAV foci and significantly 
improved the permissivity of both HeLa and MRC5 cells to transduction, again 
indicating that generation of dsDNA, and thus formation of rAAV foci, positively 
correlates with cell permissivity to transduction. Similar considerations also 
apply to the silencing of Mdcl. Interestingly, Nbsl silencing had a marked effect 
in increasing the number of cells with AAV foci; even if it modified only 
modestly the average number of foci that were present per cell.
Over the last few years, we and others have reported that cells lacking 
functional ATM are markedly more permissive to rAAV transduction (Sanlioglu 
et al., 2000; Zentilin et al., 2001). The observation that Nbsl silencing has no 
apparent effect on the level of transduction in ATM-defective cells is consistent 
with the possibility that the ATM protein might mediate the negative regulation of 
MRN protein activity on the incoming rAAV genomes. In this respect, it is worth 
noting that ATM and Nbsl have been recently shown to be essential in the 
formation of the replication protein A-coated ssDNA microcompartments 
following cell irradiation with ionizing radiations (Bekker-Jensen et al., 2006). It 
might thus be envisioned that these proteins also participate in the processing of 
the ssDNA AAV genomes. It is worth noting that the increase in transduction 
efficiency after Nbsl silencing was observed both in the absence and presence of 
HU. Indeed, the major effect of the HU treatment is to enhance the outcome of 
Nbsl silencing on AAV cell transduction. This suggests that the formation of 
MRN foci is not a pre-requisite for the accumulation of rAAV into nuclear foci
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and that they are not necessarily associated with the positive effect on AAV 
transduction observed upon Nbsl silencing.
Productive AAV replication requires coinfection with unrelated helper 
virus, such as Adenovirus or transfection of its helper genes. It is known that 
adenovirus ElB55K and E4orf6 proteins enhance rAAV transduction and wt 
AAV replication, by facilitating the conversion of the single stranded to second 
stranded viral genome synthesis through a mechanism that is not yet fully 
described (Ferrari et al., 1996; Fisher et al., 1996). Elb55K and E4orf6 form a 
complex that has been recently shown to possess ubiquitin ligase activity in 
conjunction with cellular proteins, and to promote degradation of host targets p53 
and the MRN complex (Harada et al., 2002; Querido et al., 2001; Stracker et al., 
2002). Adenovirus proteins promote MRN degradation to prevent DNA damage 
signaling and viral genome processing (Carson et al., 2003; Stracker et al., 2002).
Here we have shown that AAV is a target of MRN, and, therefore, the 
degradation of these proteins by Elb55K/E4orf6 creates a more permissive 
cellular environment for AAV replication and transduction (Figure 6.7). 
Consequently, it is conceivable to suppose that AAV may have evolved to rely on 
Adenovirus functions in order to get rid of the DNA repair proteins that hinder its 
infection process. In the present work, in collaboration with M.D. Weitzman 
(Salk Institute, La Jolla), we have also shown that the degradation of MRN by the 
Adenovirus proteins E4orf6/ElB55k results in an increase in rAAV transduction 
efficiency. Moreover, we have shown that this effect occurs independent of the 
degradation of p53 (Schwartz et al, 2006, manuscript under revision, EMBO 
Reports).
As expected, E4orf6/ElB55k-mediated degradation of MRN also 
increases the number of cells with rAAV foci. These findings, together with the
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results obtained after siRNA mediated silencing of Nbsl, further confirm that the 
MRN complex plays an inhibitory role at the level of rAAV genome processing 
and cell transduction.
Recent studies have shown that wild-type and recombinant adeno- 
associated virus (AAV and rAAV) genomes persist in human tissue 
predominantly as double-stranded (ds) circular episomes derived from input linear 
single-stranded virion DNA (Duan et al., 2003; Song et al., 2001). These data 
strongly suggest that wt and recombinant AAV genomes utilize similar host 
recombination pathways. While the correlation between long-term persistence of 
rAAV genomes and conversion to circular and concatameric forms has been noted 
in numerous studies, there is no clear consensus about the fate of the linear rAAV 
genomes. These molecular species are likely to represent a transient episomal 
phase due to the recombinogenic nature of the free DNA ends. It is therefore 
important to understand how the mammalian DNA repair and recombination 
machinery participate in the conversion of linear rAAV genomes to more stable 
structures. Undoubtedly, persistence of the vector genome in the host cell is a 
critical parameter for successful use of rAAV for gene delivery.
The homologous recombination (HR) as well as non-homologous end joining 
(NHEJ) DNA repair machineries have been implicated in different steps of rAAV 
transduction (Choi et al., 2006; Jurvansuu et al., 2005; Song et al., 2001; Song et 
al., 2004; Vasileva et al., 2006; Zentilin et al., 2001).
Previous experiments conducted in our laboratory have shown that, direct 
interaction of Rad52 with rAAV genomes, evaluated by quantitative chromatin 
immunoprecipitation, correlates with higher transduction efficiency (Zentilin et 
al., 2001). As expected, siRNA mediated silencing of Rad52 resulted in a 
decrease in transduction efficiency (Figure 6.10A).
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On the other hand, several previous studies have demonstrated that NHEJ 
repair proteins associate with the rAAV genomes and affect their molecular fate 
in different ways. It has been shown that the catalytic subunit of DNA-PK (DNA- 
PKcs) affects the efficiency of rAAV genome circularization. In mice lacking 
DNA-PKcs (SCID mice), rAAV vector DNA recovered from muscle contains a 
significant fraction of linear molecules, which are not seen in normal mice (Duan 
et al., 1998; Song et al., 2001). Our experiments show a dependence of rAAV 
(Rep-) transduction on DNA-PKcs only when cells are treated with HU, 
suggesting that the requirements of this factor would be essential in a particular 
phase of the cell cycle (i.e. Gl/S) or in the presence of cellular DNA damage 
response. Further characterization in this respect will be necessary.
Phosphorylation of histone H2AX at serine 139 (y-H2AX) is one of the 
first events after DNA damage response (Riballo et al., 2004; Rogakou et al., 
1998). Previous studies have suggested that the cell surveillance machinery may 
recognize AAV genomes as stalled replication forks (Jurvansuu et al., 2005). The 
well recognized involvement of H2AX phosphorylation in DNA repair after 
collapse of the replication fork (Furuta et al., 2003; Mirzoeva and Petrini, 2003) 
makes us think about the possible participation of H2AX in the rAAV genome 
processing. Interestingly, silencing of H2AX produces a decrease in rAAV 
transduction in the presence and absence of HU treatment; however, when DNA 
damage is induced by HU, the reduction on rAAV transduction was more 
pronounced (Figure 6.10C). Nevertheless, it is important to mention that it is not 
known what might be the chromatin structure of rAAV genomes once inside the 
cell nucleus.
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7. 2. DNA Repair machinery and AAV site-specific integration.
One of the most intriguing aspects of AAV biology is represented by the 
unique ability of this virus to integrate site-specifically into the human genome, at 
C hi9 (Bems and Linden, 1995; Linden and Bems, 2000). Several strategies have 
been used to evaluate the efficiency of AAV site-specific integration into Chi 9. 
Initial estimates of the efficiency of this process were based on the number of 
rescue-competent, latent infections that could be derived from a pool of infected 
cells (McCarty et al., 2004). In these studies, the AAV integration efficiencies 
achieved in infected cells were typically of 20%-80%. Similar results have been 
obtained using Rep-containing vectors (McLaughlin et al., 1988; Mendelson et 
al., 1988; Samulski et al., 1989). More recently, Huser et al. (2002) have 
developed a rapid and efficient assay for Chi 9 specific integration, based on 
polymerase chain reaction (PCR) amplification using primers specific for the 
AAV and flanking chromosomal sequences. Using this technique, they reported 
values of integration frequency that are consistent with earlier results and with the 
frequencies we have observed in our experiments. The use of quantitative PCR 
(qPCR) to quantify the number of site-specific integration has several advantages 
as well as some limitations that are inherent to the method and the nature of the 
AAV integration process. The technique used by us as well as the one described 
by Huser et al. (2002) have the advantage to be highly sensitive, fast and easily 
adaptable to high throughput applications. It allows us to detect and quantify the 
number of integration events in the absence of selective pressure against the cell 
that harbor the integrated viral genomes, and to collect the samples at any time 
point during the experiment without the requirement of enrichment of any cell 
population. However, the exact number of integration events needs to be 
analyzed carefully. It is important to mention that even if  the Rep-mediated
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integration of AAV genome occurs at high frequency along the AAVS1 locus, 
the break point is not identifiable and fixed. As a consequence, every single 
integration event may be potentially different from cell to cell, and eventually the 
length of the fragments produced after PCR amplification is variable (Huser et al.,
2002). Therefore, the possibility always exists that shorter PCR amplified 
fragments may be favored during the amplification reaction, resulting in a 
possible underestimation of the totality of the integration events in a given 
sample. Even in the light of these considerations, this experimental approach is 
considered the most flexible and convenient for the kind of experiments 
conducted in this study and many other biotechnological applications (McCarty et 
al., 2004).
It is known that the Rep protein is necessary for AAV site-specific 
integration into Chi 9, but the reason why this event takes place selectively at the 
AAVS1 locus, the mechanism of integration, and the role of cellular factor in this 
process remain elusive (Hamilton et al., 2004; Vasileva and Jessberger, 2005). In 
this study we attempt to identify cellular factors that may participate directly or 
indirectly in the process of Rep-dependent AAV site-specific integration. The 
remarkable inhibitory role of the proteins of the MRN complex at the level of 
rAAV genome processing and transduction prompted us to explore its possible 
participation also in the process of genome integration. Interestingly, silencing of 
Nbsl as well as Mdcl dramatically increased the frequency of integration events, 
suggesting that these proteins may interfere with the processing of the AAV 
genomes required for chromosomal integration. This line of thought is favored by 
the observation that the transduction efficiency of the AAV-Rep-GFP vector, after 
silencing of these proteins, was not dramatically affected (Figures 6.13 and 6.14).
One possible explanation for the above findings could take into account
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the known property of the Rep protein to induce DNA breaks into the host cell 
genome. The MRN complex would be eventually recruited at these sites and 
possibly titered out from the AAV genomes (Berthet et al., 2005). Alternatively, 
it is tempting to speculate that the Rep proteins would establish interactions with 
proteins involved in the repair of double strand breaks and acting as sensors, 
effectors or signal transducers and modulators of the cell cycle. In this respect, 
two examples of such interactions are the reported binding between Rep68 and 
Topors, a p53 and topoisomerase I binding protein (Weger et al., 2002), and 
between Rep68 and Replication protein A (RPA) (Stracker et al., 2004).
On the other hand, H2AX, Rad52 and DNA-PKcs silencing have shown to 
markedly decrease, in our experimental conditions, the integration efficiency. In 
the case of Rad52, a decrease in site-specific integration was also accompanied by 
a reduction in AAV-Rep-GFP transduction efficiency, measured as the percentage 
of cells positive for EGFP. Recent publications have indicated that the HR 
machinery participates in the process of AAV-mediated gene targeting, a process 
that could be, from a mechanistically point of view, similar to the Rep dependent 
site-specific integration (Vasileva et al., 2006). As previously discussed, Rad52 
proteins are know to physically interact in vivo with rAAV vector genomes 
(Zentilin et al., 2001). In light of these results, the Rad52 protein may directly 
participate in the process of integration or may be necessary for a molecular 
modification prior the integration event, such as strand annealing between AAV 
genomes of positive and negative polarities or annealing with homologous 
genomic regions.
It has been observed, however, that no large regions of homology are 
found between the AAVS1 and the wtAAV, and it has been thus suggested that 
integration occurs through a non-homologous end-joining pathway (Russell,
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2003). Small (4-5-bp) homologies at the junctions between host cell and viral 
DNA are consistent with illegitimate recombination products. Partial deletion of 
sequences within the AAV ITRs, as well as large-scale rearrangements of the host 
sequences around the integration site, suggested that the process is both complex 
and imprecise (Hamilton et al., 2004).
Transduction and site-specific integration efficiency of the Rep-containing 
AAV vector were significantly reduced after siRNA mediated silencing of both 
Rad52 and DNA-PKcs, suggesting a very complex interplay between different 
cellular factors. As already discussed (See section D.l), transduction efficiency 
of AAV-LacZ (Rep-) showed only dependence on DNA-PKcs after treating the 
cells with HU; this observation suggests a potentially differential usage, by AAV, 
of the cell machinery depending on the cell environment and its position in the 
cell cycle.
Y-H2AX foci formation has been observed in cells expressing wt AAV 
Rep protein (Berthet et al., 2005). Since the insertion of the AAV genome into the 
AAVS1 locus would require the cleavage of the chromosomal DNA, probably 
mediated by the Rep protein (Hamilton et al., 2004), in the absence of H2AX, the 
recruitment of the DNA repair machinery required for sealing the broken ends 
created during, may be impaired.
This could explain our observed decrease in site-specific integration after 
H2AX silencing. However, further studies would be necessary to clarify the 
actual role of H2AX in this process.
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7.3. Final considerations
On the basis of the results presented in this thesis, we would like to 
propose a model that explains the fate of rAAV DNA once inside the host cell 
nucleus, which entirely depends on the host cell machinery (Figure 7.1). 
According to this model, rAAV genomes, by virtue of both their ssDNA nature 
and the presence of secondary DNA structures in the viral ITRs, are recognized 
by cellular proteins involved in the DNA damage response; including MRN, 
Mdcl and components of the HR and NHEJ machinery. MRN complex proteins 
and Mdcl are inhibitory of ssDNA to dsDNA genome conversion, and, thus, are 
detrimental for efficient transduction. Only once this inhibition is eluded, the 
genomes might be converted to dsDNA by either second strand DNA synthesis 
utilizing the hairpin ITRs in a self-priming replication mechanism, or by the direct 
annealing of the complementary DNA strands of the incoming vectors (Fisher et 
al., 1996; Hauck et al., 2004). Cell treatment with DNA damaging agents might 
divert the inhibitory proteins away from the rAAV genomes, and this would 
explain the positive effects of genotoxic agents on rAAV transduction. 
Consequently, degradation of MRN complex by means of Adenovirus 
ElB55k/E4orf6 complex exerts a positive effect on AAV transduction similar to 
the one observed after HU treatment.
After ssDNA to dsDNA conversion, the vector genome is known to 
undergo additional changes, which are mediated by host cell factors acting on the 
AAV ITR ends. These changes involve circularization of the vector DNA, or the 
formation of end-to-end concatamers (reviewed in McCarty et al., 2004). Cellular 
proteins that participate in HR and NHEJ may either play a role at this level or, 
more likely as in the case of Rad52, in the process of annealing of rAAV genomes 
of positive and negative polarity.
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It is possible to speculate that histone H2AX may get phosphorylated at the 
moment of concatamer formation and/or at the moment of integration.
H2AX may be assembled into the AAV dsDNA genomes, as well as 
present in the target genomic AAVS1 locus. Phophorylation of either viral or 
AAVS1 H2AX may be required to trigger a DNA damage response that will end 
with the integration of the viral DNA into the host chromosome. Further studies 
about the structure and composition of the rAAV chromatin may help to explain 
these findings.
A recent work that exploited self-complementary AAV vectors, which 
bypass the ssDNA to dsDNA conversion step, because their genomes are already 
dsDNA, has shown that ATM and MRN proteins participate in AAV genome 
circularization (Choi et al., 2006). Thus, it might be envisioned that these 
proteins, while being inhibitory on the input single-stranded viral genome either 
by impeding dsDNA synthesis or by routing the genomes to aberrant processing 
or nucleolytic degradation, might become positive factors when dsDNA synthesis 
has already occurred. At this stage, resolution of the secondary structures in the 
ITRs by promoting circulation or multimerization might be essential to allow 
stable maintenance of the viral genomes inside the nucleus.
Does genome integration require the formation of dsDNA AAV genomes? 
The clarification of the exact nature of the substrate required for site-specific 
integration is of fundamental importance; in this respect the used of self- 
complementary Rep containing AAV could give some valuable information.
H2AX, Rad52 and DNA-PKcs proteins may be required for the processing 
of the AAV in order to generate multimerized genomes competent for 
transcription or/and suitable substrate for Rep dependent site-specific integration.
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On the other hand, the proteins of the MRN complex and Mdcl exert inhibitory 
roles both at transcription and at site-specific integration.
Finally, we wish to emphasize that one of that one of most challenging but 
still unanswered questions related to rAAV vectors is the explanation, in 
molecular terms, of their exquisite efficiency in post-mitotic tissues in vivo, such 
as brain, retina and heart (Carter et al., 2004). Our findings prompt the 
investigation of the levels and activity of MRN complex proteins, HR and HHEJ 
pathways in these tissues.
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